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Acinetobacter baumannii has emerged as an important, multidrug resistant (MDR) pathogen 
causing a wide spectrum of disease conditions in humans. The emergence of multi-drug, pan-
drug resistant, and extended drug-resistant strains of A. baumannii, which are resistant to almost 
all classes of antibiotics, makes the treatment of A. baumannii infections difficult. The ubiquitous 
presence of A. baumannii in water and soil along with its ability to persist under various 
environmental conditions aids in the potential contamination of foods, especially fresh produce. 
Further, the genotypic and phenotypic similarities among various species of Acinetobacter 
impede the specific detection of A. baumannii in clinical and environmental samples.  
In this dissertation, the prevalence of A. baumannii on fresh vegetables collected from 
farmers’ markets in Connecticut was studied. The results showed the presence of a variety of 
MDR opportunistic pathogens, including A. baumannii on vegetables. In addition, the effect of 
chlorine, a commonly used disinfectant in water, was tested for its efficacy in killing A. 
baumannii, besides determining its effect on the antibiotic resistance genes in the bacterium. 
Chlorine was not only found ineffective to inactivate significant populations of A. baumannii in 
water, but also induced the expression of major antibiotic resistance genes in the pathogen.  
 A real-time quantitative PCR targeting a highly conserved 102-bp DNA sequence in adeT, 
an efflux pump gene found only in A. baumannii, was developed for rapid and specific detection 
of the bacterium in water and blood. The PCR detected all the A. baumannii isolates by 
 
amplifying a 107-bp DNA fragment, however, none of the tested negative isolates, including 
other closely related Acinetobacter species produced any amplification. The sensitivity of PCR 
for detecting A. baumannii in blood and water was 3 log10 CFU/ml or 0.1 ng/ml of DNA. 
However, with an enrichment step, the PCR was able to detect 2 log10 and 1 log10 CFU/ml of A. 
baumannii in water after 6 h and 14 h of incubation at 37oC, respectively.  
Because of A. baumannii’s resistance to most of the currently used antibiotics, this 
dissertation also investigated the efficacy of two plant-derived antimicrobials (PDAs), trans-
cinnamaldehyde (TC) and eugenol (EG) in reducing its resistance to seven commonly used β-
lactam antibiotics.  Both TC and EG were effective in significantly increasing the sensitivity of 
A. baumannii to the selected beta-lactam antibiotics. Further, it was revealed that TC and EG 
down-regulated the expression of major genes conferring antibiotic resistance in the bacterium.  
A. baumannii has been increasingly linked to persistent wound infections, especially in 
burn victims and combat-related injuries. A. baumannii’s multi-drug resistance and ability to 
form biofilms and colonize skin epithelial cells limit the efficacy of currently used wound 
infection treatments. Therefore, this dissertation determined the efficacy of TC and EG in 
decreasing A. baumannii adhesion to and invasion of human keratinocytes, in addition to 
inhibiting A. baumannii biofilm formation using an in vitro wound model. Both TC and EG 
significantly reduced A. baumannii colonization of skin cells, and biofilm production, suggesting 











  i 














B. Tech., Kerala Agricultural University, 2006 













Submitted in Partial Fulfillment of the Requirements for the  
Degree of Doctor of Philosophy 








  2 
 
  ii 
APPROVAL PAGE 
Doctor of Philosophy Dissertation 
 
Acinetobacter baumannii: A Study on Prevalence, Detection and Virulence 
 
Presented by 





























Dr. Paulo Verardi 
 
 
University of Connecticut 2015 
  iii 
ACKNOWLEDGMENTS 
With immense pleasure, I place on record my entire debt of gratitude to my major advisor 
Dr.Kumar Venkitanarayanan for his stimulating ideas, meticulous guidance, and generosity with 
time and funding which made my Ph.D experience very productive and fruitful. It has been a 
privilege to have known him and a great learning experience to have been part of his research 
group. 
I gratefully avail this opportunity to express my respect and sincere thanks to Dr. Cameron 
Faustman, for being my course teacher and also for the encouragement and apposite help 
extended to me throughout my doctoral program. 
Words of thanks to Dr. Paulo Verardi and Dr. Mary Anne Roshni Amalaradjou, for their 
valuable and propitious suggestions provided for the accomplishment of this work. 
My deepest sense of appreciation to Dr. Steve Zinn for his unstinted support extended to me 
during my doctoral program at University of Connecticut. 
I warmly acknowledge Dr. Anup Kollanoor-Johny and Dr. Sangeetha Ananda Bhaskaran, my 
senior colleagues at the Food microbiology laboratory and also to my lab mates and friends 
Abhinav, Shan, Indu, Hsin-Bai, Chi-Hung, Fulin Ma, Varun, Meera, Genevieve, and Samantha 
for their help and support throughout my experimental studies. I value their friendship and 
support throughout my PhD program. 
I would like to thank Dr. Antonio Garmendia for providing me the facilities of Pathobiology 
laboratory for my research.  I express my gratitude and appreciation to the faculty and staff of the 
Department of Animal Science for their assistance and co-operation with various administrative 
works. A special thanks to Tina Burnham and Kathy Noyes for their constant help they rendered 
  iv 
to me for all my needs. I gratefully acknowledge the funding sources that made my Ph.D work 
possible, as well as the Institute of Health Management Associates for providing A. baumannii 
strains used in the study. 
Last but not the least, I express my deep gratitude to my loving family. My parents, Dr.V.Prasad 
and Daksha Prasad for their unconditional love and care. They have always been there for me at 
every step of my life. The wholehearted support and encouragement of my husband, Reju has 
































  v 
 
 
TABLE OF CONTENTS 
 
Approval page……………………………………………………………………………… i 
Acknowledgements ………………………………………………………………………... ii 
Table of contents ……………………………………………………………………………iv 
List of figures ……………………………………………………………………………….ix 
List of tables ……………………………………………………………………………..….xiii 
List of abbreviations ……………………………………………………………………..…xiv 
Chapter I: Introduction……………………………………………………………...……1 
Chapter II: Review of Literature…………………………………………………………6 
1. Taxonomy of Acinetobacter…………………………………………………………7 
2. Morphology, physiological and biochemical characteristics………………….……9 
3. Natural Habitats……………………………………………………………………10 
4. Pathogenicity of Acinetobacter infections and virulence………………..…………13 
4.1. Cell surface hydrophobicity and enzymes…………………………….….……13 
4.2. Toxic slime polysaccharides………………………………….………….…… 14 
4.3. Outer membrane protein…………………………………………….…………14 
4.4. Surface and mitochondrial porins…………………………………...…………15 
4.5. Siderophores……………………………………………………….……...……15 
5. Biofilm formation…………………………………………………………...………16 
6. Clinical manifestations of A. baumannii infections……………...…………………18 
7. Antibiotic resistance…………………………………………….…………..………20 
8. Plant-derived antimicrobials…………………………………………..……………24 
  vi 
9. Summary………………………………………………………………………………….……26 
References …………………………………………………………………..……….28 
Chapter III: Prevalence of MDR A. baumanniion fresh vegetables collected from farmers 
market in Connecticut...........................................................................................................47 
Abstract ………………………………………………………………………..…….………48 
1. Introduction ………………………………………………………...……..…………50 
2. Materials and Methods ………………………………………………………………52 
2.1 Sample collection and detection of Acinetobacter spp.…………… …………….52 
2.2 Identification and characteristics of the isolates…………………………………53 
2.3 Antibiotic susceptibility testing……………………………………………...……54 
3. Results and discussion ……………………………………………………….………54 
References ……………………………………………………………………………...….…59 
Chapter IV: Effect of chlorine on A. baumannii survival in water and expression of 
antibiotic resistance genes ………………………………………………………………….67 
Abstract ………………………………………………………………………………...…….68 
1. Introduction ………………………………………………………….……………….70 
2. Materials and Methods……………………………………………………….….……71 
2.1. A. baumannii strains and growth conditions……………………………….….…71 
2.2. A. baumannii survival assay………………………………………….……..……72 
2.3. Antibiotic resistance gene expression………………………………...………..…73 
2.3.1. RNA isolation and cDNA synthesis…………………………………….….73 
2.3.2. Real-time quantitative PCR (RT-qPCR)…………………………………..74 
2.4. Statistical analysis…………………………………………………………...……74 
  vii 
3. Results and discussion. ………………………………………………………………..75 
References………………………………………………………………………………….….78 
Chapter V: A real-time quantitative PCR for specific detection of A. baumannii in water 
and blood ………………………………………….…………………………………….…....87 
Abstract……………………………………………………………………………..………....88 
1. Introduction………………………………………………………………………...….89 
2. Materials and methods……………………………………………...……………...…..91 
2.1. Bacterial strains and growth conditions…………………….………………........91 
2.2. Preparation of genomic DNA……………………………………….……………91 
2.3. Detection of A. baumannii in water and blood on pre-enrichment……………….91 
2.4. Primers for A. baumannii specific PCR………………………………….……….92 
2.5. Real-time TaqMan PCR assay……………………………………………………92 
3. Results and discussion ………………………………………………………..………93 
References ……………………………………………………………..……………..…..96 
Chapter VI: Effect of Trans-cinnamaldehyde and Eugenol on decreasing A. baumannii 
resistance to selected β-lactam antibiotics……………………………………………..106 
Abstract………………………………………………………………………………...…107 
1. Introduction………………………………………………………....………………...109 
2. Materials and methods………………………………………..………………………111 
2.1. A. baumannii cultures and growth conditions…………………………………...112 
2.2. Plant derived antimicrobials (PDAs) and chemicals………………..…………..112 
2.3. Determination of sub-inhibitory concentration (SIC) and minimum inhibitory 
concentration (MIC) of PDAs against A. baumannii……………………..……..112 
  viii 
2.4. Effect of PDAs on antibiotic resistance in A. baumannii………………....…….112 
2.5. Efflux pump inhibition assay………………………………………………...….113 
2.6. Outer membrane permeabilization…………………………………..………….114 
2.7. Effect of PDAs on antibiotic resistance gene expression in A. baumannii...........114 
2.7.1. RNA extraction and cDNA synthesis…………………………………….115 
2.7.2. Real time quantitative PCR (RT-qPCR)…………………………………115 
2.8. Statistical analysis……………………………………………………………....115 
3. Results ……………………………………………………………………………....116 
4. Discussion……………………………………………………………………..….…118 
References……………………………………………………………………………….121 
Chapter VII: Efficacy of trans-cinnamaldehyde and eugenol in reducing A. baumannii 




2. Materials and Methods……………………………………………………………….151 
2.1. Bacterial strains and growth conditions……………………………….………..151 
2.2. Plant Derived Antimicrobials (PDAs)…………………………………………...151 
2.3. Determination of Sub-inhibitory and Minimum inhibitory concentration (SICs and 
MICs) of PDAs……………………………………………………………….….151 
2.4. Keratinocyte cell culture……………………………………………………..….152 
2.5. Adhesion and invasion assay……………………………………………………152 
2.6. Quantification of biofilm in In vitro wound model……………………………...153 
  ix 
2.7. Confocal microscopy……………………………………………………….……154 
2.8. Effect of TC and EG on biofilm genes in A. baumannii…………………………155 
2.8.1. RNA extraction and cDNA synthesis……………………………….……156 
2.8.2. Real-Time Quantitative PCR (RT-qPCR)……………………………….156 
2.9. Statistical analysis………………………………………………………………156 
3. Results and Discussion………………………………………………………………156 
References……………………………………………………………………………….160 
















  x 
 
List of Figures 
 
 Title Page 
 Chapter II  
FIG 1 Effect of chlorine exposure on A. baumannii ATCC 17978 antibiotic 
resistance gene expression 
85 
FIG 2. Effect of chlorine exposure on A. baumannii 251847 antibiotic 
resistance gene expression 
85 
FIG 3 Effect of chlorine exposure on A. baumannii 474030 antibiotic 
resistance gene expression 
                                                 Chapter III 
86 
FIG 1 Specificity of the primer-probe set in differentiating A. baumannii from 
other members of ABC complex  
101 
FIG 2 Specificity of the primer-probe set in differentiating A. baumannii from 
other important Gram-negative and Gram-positive pathogens used as 
negative controls 
101 
FIG 3 (A) Sensitivity of the primer-probe set in detecting A. baumannii in 
water 
(B) Standard curve generated from the amplification plot 
102 
FIG 4 (A) Sensitivity of the primer-probe set in detecting A. baumannii in 
blood 
(B) Standard curve generated from the amplification plot 
103 
  xi 
FIG 5 (A) Sensitivity of the primer-probe set in detecting A. baumannii DNA 
(B) Standard curve generated from the amplification plot 
104 
FIG 6 Sensitivity of the primer-probe set in detecting A. baumannii in water 
after enrichment 
(A)Following 6 h of incubation at 37OC (B) Following 14 h of 
incubation at 37OC 
105 
FIG 1 Effect of TC in combination with beta-lactam antibiotics in A. 
baumannii 17978 
129 
FIG 2 Effect of TC in combination with beta-lactam antibiotics in A. 
baumannii 251847 
130 
FIG 3 Effect of EG in combination with beta-lactam antibiotics in A. 
baumannii 17978 
131 
FIG 4 Effect of EG in combination with beta-lactam antibiotics in A. 
baumannii 251847 
132 
FIG 5 Intracellular accumulation of ethidium bromide (EtBr) in A. baumannii 
ATCC 17978 after treatment with MIC of TC and EG as measured by 
fluorescence intensity. 
133 
FIG 6 Intracellular accumulation of ethidium bromide (EtBr) in A. baumannii 
251847 after treatment with MIC of TC and EG as measured by 
fluorescence intensity. 
134 
FIG 7 Intracellular accumulation of pyronin Y in A. baumannii ATCC 17978 
after treatment with MIC of TC and EG as measured by fluorescence 
intensity. 
135 
  xii 
FIG 8 Intracellular accumulation of pyronin Y in A. baumannii 251847 after 
treatment with MIC of TC and EG as measured by fluorescence 
intensity. 
136 
FIG 9 Effect of TC and EG on A. baumannii17978 outer membrane as 
measured by fluorescence intensity. HEPES buffer (5.0 mM) was used 
as a control. 
137 
FIG 10 Effect of TC and EG on A. baumannii251847 outer membrane as 
measured by fluorescence intensity. HEPES buffer (5.0 mM) was used 
as a control. 
138 
FIG 11A Effect of TC /EG either alone or in combination with Amoxicilllin  139 
FIG 11B Effect of TC /EG either alone or in combination with Ampicillin  140 
FIG 11C Effect of TC /EG either alone or in combination with Piperacillin  141 
FIG 11D Effect of TC /EG either alone or in combination with Aztreonam  142 
FIG 11E Effect of TC /EG either alone or in combination with Meropenem  143 
FIG 11F Effect of TC /EG either alone or in combination with Penicillin  144 




FIG 1 Effect of MICs of TC and EG on A. baumannii Naval-17 adhesion to 
and invasion of HEK001 keratinocytes 
167 
FIG 2 Effect of MIC of TC and EG on A. baumannii OIFC 109 adhesion to 
and invasion of HEK001 keratinocytes 
168 
FIG 3 Effect of MICs of TC and EG on A. baumannii WC-487 adhesion to and 
invasion of HEK001 keratinocytes 
169 
  xiii 
FIG 4 Effect of MICs of TC and EG on A. baumannii Naval -17 biofilm in an 
in vitro wound model 
170 
FIG 5 Effect of MICs of TC and EG on A. baumannii OIFC 109 biofilm in an 
in vitro wound model 
171 
FIG 6 Effect of MICs of TC and EG on A. baumannii WC-487 biofilm in an in 
vitro wound model 
172 
FIG 7 Scanning confocal micrographs of Acinetobacter baumannii Naval-17 
biofilm 
173 
FIG 8 Effect of TC and EG on biofilm genes in A. baumannii Naval-17 174 















  xiv 
List of Tables 
 Chapter I Page 
TABLE 1. List of primers used in confirming bacteria isolated from 
vegetables from Farmers markets 
66 
TABLE 2. Prevalence of Multi-drug resistant bacteria in vegetables from 
Farmers’ markets in Connecticut 
66 
TABLE 3. Antibiotic resistance profile of the isolates 66 
 Chapter II  
TABLE 1. List of primers used in determing the effect of chlorine on 
antibiotic resistance genes in A. baumannii 
82 
TABLE 2. Effect of chlorine concentrations on the survival of A. baumannii in 
deionized water 
83 
 Chapter III  
TABLE 1. List of bacterial strains used in detecting specificity of PCR 99 
 Chapter IV  




TABLE 2. MIC of antibiotics used in testing against A. baumannii 128 
 Chapter V  





  xv 
List of Abbreviations 
 
ATCC American Type Culture Collection 
CCCP Carbony cyanide m-chlorophenylhydrazone 
CDC Centers for Disease Control and Prevention 
CFU Colony Forming Unit 
CR Carvacrol 
CSPI Center for Science in the Public Interest 
EDTA Ethylene diamine tetraacetic acid 
EG Eugenol 
EPA Environmental Protection Agency 
EPS Extracellular polymeric substance 
EtBr Ethidium bromide 
FAO Food and Agriculture Organization 
FDA Food and Drug Administration 
GRAS Generally recognized as safe 
ICU Intensive Care Unit 
MBC Minimum bactericidal concentration 
MDR Multi drug Resistant Bacteria 
MIC Minimum inhibitory concentration 
MPN Most Probable Number 
NPN 1-N-phenylnapthylamine 
PBS Phosphate buffer saline 
  xvi 
PDA Plant-derived antimicrobial 
PPM Parts Per Million 
RT-qPCR Real-time quantitative polymerase chain reaction 
SAS Statistical analysis software 
SIC  Sub-inhibitory concentration 
TC Trans-cinnamaldehyde 
TSA Tryptic soy agar 
TSB Tryptic soy broth 
USDA United States Department of Agriculture 
USDH United States Department of Health 


































Bacterial antimicrobial resistance has emerged as one of the most serious public health threats 
globally. The Centers for Disease Control and Prevention (CDC) reported that antibiotic-resistant 
infections account for two million illnesses and 23,000 deaths annually in the US, with over $20 
billion as direct health-care costs and $35 billion in lost productivity (CDC, 2013). The problem 
is further exacerbated by the lack of new and effective antibiotics under development against 
multi-drug resistant (MDR) pathogens (Maragakis and Perl, 2008; Manchanda et al., 2010). 
Acinetobacter baumannii has emerged into a significant MDR pathogen, especially linked to 
infections associated with hospitals and intensive care units (Giamarellou, 2010; Medell et al, 
2013). The Infectious Diseases Society of America has ranked A. baumannii as one of the top 
priority, antibiotic-resistant pathogens to target, due to its rapid propensity to develop drug 
resistance, and the restricted choice of antibiotics to treat infections caused by the bacterium 
(Talbot et al., 2006). In humans, MDR A. baumannii causes a variety of infections, including 
pneumonia (Leung et al., 2006), blood-stream infections (CDC, 2004; Wisplingoff et al., 2004), 
meningitis (Metan et al., 2007), and urinary tract infections (Gaynes and Edwards, 2005). In 
addition, MDR A. baumannii has been increasingly linked to wound infections in burn victims 
(Bergogne-Berezin, 1995; Santucci et al., 2003; Sharma, 2007), and combat-related wound 
injuries (Scott et al., 2007; Murray and Hospenthal, 2008). 
 A. baumannii is ubiquitously distributed in nature because of its ability to persist under a 
wide variety of environmental conditions for extended periods of time (Maragakis and Perl, 
2008). Acinetobacter spp., including A. baumannii are frequently isolated from soil and water 
(Baumann et al; 1968; Berlau et al., 1999; Houang et al., 2001; Dijkshoorn et al., 2007;Cateau et 
al., 2011), thereby potentially serving as a source of food contamination, especially fruits and 
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vegetables. Protozoans such as Acanthamoeba are reported to support A. baumannii growth in 
aquatic ecosystems, and act as a reservoir of the pathogen (Cateau et al., 2011). A limited 
number of studies conducted outside the United States have isolated A. baumannii and other 
Acinetobacter spp. from a variety of foods, including bulk tank milk (Gurung et al., 2013), raw 
meat (Houang et al., 2001; Lupo et al., 2014), fresh produce (Berlau et al.,1999), and fish 
(Houang et al., 2001). Since fruits and vegetables are more vulnerable to contamination by 
antibiotic resistant bacteria from soil and water due to their cultivation patterns, and are not 
generally subjected to any terminal lethal process or cooking, the potential for transfer of 
resistant determinants to commensal or pathogenic bacteria in the human gut is greater. 
 The detection of A. baumannii by conventional bacteriological methods requires at least 48 
to 72 h for obtaining accurate results (Levi et al., 2003; Jamal et al., 2014). Furthermore, the four 
Acinetobacter species grouped under A. baumannii -A. calcoaceticus complex (ABC),including 
A. calcoaceticus, A. baumannii, A. pitti  and A. nosocomalis, are phenotypically and 
genotypically closely related, and are difficult to be distinguished from each other. Further, 
species identification using biochemical tests fails to differentiate A. calcoaceticus from A. 
baumannii, and specific detection needs to be followed up by further tests, which could be time 
consuming in clinical diagnosis. Thus, there is a need for rapid and accurate assays for specific 
detection of A.baumannii in clinical and environmental samples.  
          A. baumannii is resistant to most of the currently available antibiotics (Hsueh et al., 2002; 
Lin et al 2014). Further, A. baumannii possesses almost all known antibacterial resistance 
mechanisms reported in bacteria, including the ability to acquire multidrug-resistance from other 
bacteria through plasmids, transposons and integrons, reduced permeability of outer membrane 
to some antibiotics, and the constitutive expression of efflux pumps (Vila and Pachon, 2008). 
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Since there are limited therapeutic options against A. baumannii, there is a critical need to 
explore novel strategies for controlling antibiotic resistance in the bacterium.  
 For centuries, plants have served as a basis for the development of novel drugs, thereby 
contributing to human health.  Plants are capable of synthesizing a large number of molecules, 
most of which are phenolic compounds or their derivatives (Geissman, 1963; Burt 2004; Holley 
and Patel, 2005; Savoia, 2012). Plants produce a majority of these compounds as a defense 
mechanism against predation by microorganisms and insects (Cowan, 1999). A variety of plant-
derived polyphenols serve as dietary ingredients as well as active components in a number of 
herbal and traditional medicines (Wollenweber, 1988). Several plant-derived essential oils have 
demonstrated antimicrobial activity towards a wide range of microorganisms, and several active 
components of these oils have been identified (Burt, 2004; Holley and Patel, 2005).  
          Although considerable literature exists on the antimicrobial properties of several plant 
derived antimicrobials (PDAs) on a wide range of microorganisms, relatively limited information 
is available on their effect on bacterial antibiotic resistance, especially in Gram-negative 
pathogens. Previous research conducted in our laboratory revealed that several PDAs, including 
trans-cinnamaldehyde, carvacrol, eugenol and thymol decreased antibiotic resistance in MDR S. 
Typhimurium DT 104 (Kollanoor-Johny et al., 2010). Similarly, Chusri et al. (2009) observed 
that two plant molecules, ellagic acid and tannic acid when used as adjuvant enhanced the 
antimicrobial activity of novobiocin, coumermycin, chlorobiocin, rifampicin and fusidic acid 
against A. baumannii.  
          Based on the published literature and preliminary research conducted in our laboratory, it 
was hypothesized that fresh vegetables could be a potential source of MDR A. baumannii, and 
chlorine is ineffective as a water disinfectant for killing the bacterium. In addition, it was 
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hypothesized that trans-cinnamaldehyde and eugenol reduce MDR A. baumannii’s resistance to 
selected β-lactam antibiotics, and could be used for controlling wound infections of A. 
baumannii. 
The specific objectives include of this dissertation are to 
1. Investigate the prevalence of MDR A. baumannii on fresh vegetables collected from farmers’ 
markets in Connecticut. 
2. Determine the effect of chlorine on A. baumannii survival in water and expression of 
antibiotic resistance genes 
3. Develop a real-time quantitative PCR for specific detection of A. baumannii in water and 
blood. 
4. Determine the effect of TC and EG on decreasing A. baumannii resistance to β-lactam 
antibiotics, and  
5. Investigate the efficacy of TC and EG in reducing A. baumannii adhesion to and invasion of 



































2. REVIEW OF LITERATURE 
1. Taxonomy of Acinetobacter 
In 1911, a Dutch microbiologist named Beijerinck M.W. isolated a bacterium from soil using a 
minimal medium enriched with calcium acetate, and named it as Micrococcus calcoaceticus 
(Howard et al., 2012). After 43 years, Brisou and Prevott in 1954, proposed the genus 
Acinetobacter to differentiate this bacterium from the motile organisms within the genus, 
Achromobacter (Brisou and Prevot, 1954; Towner, 1992). Subsequently extensive acceptance for 
the genus Acinetobacter was given following a comprehensive study of Micrococcus calco-
aceticus, Alcaligenes hemolysans, Mima polymorpha, Moraxella lwoffi, Herellea vaginicola and 
Bacterium anitratum by Baumann et al. (1968). The conclusion of this study was that the above 
organisms belonged to a single genus, and further sub-classification into different species based 
on phenotypical characteristics was not possible. The results of Baumann’s 1968 publication 
regarding the genus Acinetobacter was later officially acknowledged by the sub-committee on 
the Taxonomy of Moraxella and Allied Bacteria (Lessel, 1971). 
In the Bergey’s Manual of Systematic Bacteriology (Lautrop,1974), the genus 
Acinetobacter was listed with the description of a single species Acinetobacter calcoaceticus, the 
type strain being A. calcoaceticus ATCC 23055. However, in the “Approved list of bacterial 
names” two different species, A. calcoaceticus and A. lwoffii were included considering the 
ability of some Acinetobacters to acidify glucose, whereas others did not (Skerman, 1980). The 
current definition of the genus Acinetobacter is Gram-negative, strictly aerobic, non-fermenting, 
non-fastidious, non-motile, catalase-positive, oxidase-negative bacteria with a DNA G + C 
content of 39 to 47% (Albrecht et al., 2006). Currently, based on the DNA-DNA hybridization 
studies made by Bouvet and Grimnot in 1986, the genus Acinetobacter consists of 26 named 
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species and nine genomic species (Di Nocera, 2011). Acinetobacter species have phenotypic 
similarities and are difficult to differentiate among A. calcoaceticus, A. baumannii, 
Acinetobacter genomic species 3 and Acinetobacter genomic species 13TU (Gerner-Smidt, et al 
1991). 
The genus Acinetobacter is now classified in the family Moraxillaceae. The important 
genera within Moraxillaceae include Moraxella, Acinetobacter, Psychrobacter, and related 
organisms (Rossau et al., 1991). Acinetobacter genomospecies 2 (A. baumannii) is the principal 
pathogen associated with human diseases (Seifert et al., 1993; Gales et al., 2001). In addition, 
less frequently reported pathogenic species such as Acinetobacter calcoaceticus (formerly 
Acinetobacter genomospecies 1), Acinetobacter pittii (formerly Acinetobacter genomospecies 3) 
and Acinetobacter nosocomalis (formerly Acinetobacter genomospecies 13TU) are included in 
the genus. These bacteria together with A. baumannii are commonly referred to as A. baumannii-
calcoaceticus complex due to their close genotypic similarity and the difficulty in differentiating 
by normal phenotypic methods (Seifert et al., 1993; Houang et al., 2001),  
Although substantial progress has been achieved in the species level identification of 
Acinetobacter, several problems and inconsistencies still exist in the process. In the currently 
described DNA–DNA hybridization groups, only 17 of them have valid names. The remaining 
hybridization groups were considered too small (< 10 strains) to describe their characteristics as 
a group, and the criteria for phenotypic differentiation were inadequate (Bouvet and Grimont, 
1986; Bouvet and Jeanjean, 1989; Tjernberg and Ursing, 1989; Gerner Smidt and Tjernberg, 
1993; Peleg et al., 2008). Therefore, no definite species names were provided (Bouvet and 
Grimont, 1986; Bouvet and Jeanjean, 1989; Tjernberg and Ursing, 1989; Gerner- Smidt and 
Tjernberg, 1993). These limitations in species identification methods of Acinetobacter are 
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considered an impediment for elucidating the biology, pathogenicity and ecology of the 
organism at the species level.  
2. Morphology, physiological and biochemical characteristics 
The Acinetobacter is identified as Gram-negative, catalase-positive, oxidase-negative, 
non-motile, non-fermenting coccobacilli. Although Acinetobacter is considered as non-motile, 
there are reports on differential motility in response to factors, including illumination (Mussi et 
al., 2010), quorum sensing (Clemmer et al., 2011), and iron chelation (Eijkelkamp et al., 2011). 
Although not decisively proven, Acinetobacter spp. can move on semi-solid surfaces by 
expressing twitching motility rather than gliding, sliding, swimming, or swarming motility 
(Barker and Maxted, 1975; Henrichsen, 1984; Eijkelkamp et al., 2011). When subjected to Gram 
staining, the bacteria are often difficult to de-stain and are incorrectly identified as Gram-
positive. Currently there are no well-defined and definite metabolic tests for distinguishing 
Acinetobacter from other non-fermenting Gram-negative bacteria (Peleg et al., 2008). However, 
for the differentiation of Acinetobacter from other similar non-fermenting organisms, the 
negative oxidase test is used for rapid presumptive identification.  
Acinetobacter can be easily grown on simple microbiological media and the colony 
characteristics include smooth, dome shaped, pale yellow to grayish, and with entire edge (Doi et 
al 2011). The colonies of A. calcoaceticus-A. baumannii complex can grow to a size of 1.5 to 3 
mm in diameter in an overnight culture similar to that of Enterobacteriaceae, whereas  majority 
of other Acinetobacter species produce smaller colonies (Peleg et al., 2008). Although most 
Acinetobacter species can grow at ambient temperatures, the pathogenic species, A. baumannii 
grows very well at 37℃. For recovering Acinetobacter isolates from complex samples, 
enrichment medium such as Leeds selective medium is used (Doi et al., 2011). However, 
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Baumann et al (1968) reported that Acinetobacters from environmental and clinical specimens 
could be recovered by growing aerobically in an acidic enrichment medium containing acetate as 
a carbon source and nitrate as nitrogen source.  A. baumannii has been reported to possess a thick 
cell wall which protects the organism from dry conditions, besides providing high tolerance to 
temperature, pH and nutrient changes (Vila et al., 2007; Kramer et al., 2006; Houang et al., 
1998). 
3. Natural Habitats and Sources 
Water and soil are considered as major habitats of A. baumannii although the pathogen 
has been isolated from other sources, including foods, arthropods, animals, and humans 
(Baumann et al 1968; Berlau et al., 1999; Mussi et al., 2005; Fournier and Richet, 2006; Munoz-
Price and Weinstein, 2008). Moreover, protozoans such as Acanthamoeba are reported to support 
the growth of A. baumannii, and act as its reservoir in water (Cateau et al 2011). Recently, 
studies indicated the potential presence of A. baumannii in water systems from multiple parts of 
the world (Catel-Ferreira et al., 2011; Zhang et al., 2013).  
Although a limited number of studies have revealed the presence of A. baumannii on a 
variety of foods, the pathogen has not been implicated in any food-borne disease outbreaks.  In a 
study conducted in South Korea, A. baumannii strains showing different antimicrobial resistance 
patterns were isolated from bulk tank milk (Gurung et al., 2013). Out of the 2,287 bulk tank milk 
(BTM) sampled from different provinces in Korea, Acinetobacter spp. were isolated from 176 
BTM samples, of which 57 isolates were identified as A. baumannii. The presence of 
Acinetobacter spp. in BTM has been attributed to the contamination from environmental sources 
such as teat, udder surfaces, milking machines, and contaminated water used for cleaning. This 
could represent a potential source for resistance genes as they may survive pasteurization (Jain 
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and Danziger, 2004). Similarly, the isolation of Acinetobacter spp. from goat milk samples from 
Kenya at a rate of 5% was reported (Ndegwa et al., 2001).  
Berlau and colleagues (1999), while studying the prevalence of Acinetobacter spp. in 
fresh produce in the United Kingdom, reported that 17% of the samples tested positive for the 
bacteria, including A. baumannii.  These investigators observed that 56% of the Acinetobacter 
belonged to A.baumannii-calcoaceticus group, which were found on apple, melon, bean, 
cabbage, cauliflower, carrot, potato, radish, lettuce, cucumber, pepper, mushroom, and sweet 
corn. Houang et al. (2001) found A. baumannii and genomospecies 3 on vegetables, pork, beef, 
and freshwater fish procured from local markets in Hong Kong. Acinetobacter spp. was present 
in 27 of the 36 meat samples, 21 of 41 vegetable samples, and 26 of 38 fish samples screened. In 
another study, Gennari and Lombardi (1993) observed that out of 170 strains isolated from 
foods, including fresh and spoiled meat and fish, vegetables, raw milk and cheese, A. lwoffii was 
confirmed in over half of the isolates, whereas 11% and 5% of the isolates were A. johnsonii and 
A. baumannii, respectively indicating that foods could be a potential source of A. baumannii. In a 
recent study from Switzerland, Lupo et al. (2014) isolated A. baumannii from 25% of the meat 
samples, where 48 % of the positive food samples were poultry meat. The isolated strains 
displayed resistance to third and fourth generation cephalosporins, which are currently used for 
treating human infections.  
A. baumannii has been reported to colonize the skin, nostrils, and throat of healthy people 
(Seifert, et al., 1997; Chu et al., 1999; Dijkshoorn et al., 2005; Montefour et al., 2008). A 
common route for spread of A. baumannii in the hospital environment has been reported to be 
unclean hands of the hospital staff (Jalalpour and Abdol, 2012).  Further, it has been indicated 
that A. baumannii strains once colonized can remain for weeks in the body of patients 
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(Dijkshoorn et al., 2007).Therefore, stringent personal hygiene and cleanliness are critical for 
preventing the pathogen transmission (Allegranzi et al., 2009). Besides humans, La Scola and 
Raoult (2004) reported that 22% of body lice sampled from homeless people tested positive for 
A. baumannii, thereby suggesting that these parasites could also act as a potent reservoir of the 
pathogen.  
Another major source of A. baumannii is the hospital environment, where its persistence 
is attributed to the ability to grow under various temperatures and pH conditions, and more 
importantly to tide over unfavourable conditions such as desiccation, nutrient starvation and 
treatment with disinfectants (Wendt et al., 1997; Perez et al., 2007; Wisplinghoff et al., 2007; 
Gaddy and Actis, 2009). This is achieved by the ability of A. baumannii to form biofilms on 
abiotic surfaces in the hospital environment, which protects the pathogen from disinfectants, 
thereby helping it to persist for a long duration and act as a permanent source of infection 
(Gaddy et al., 2009; Shin et al., 2009; Moultrie et al., 2011; Pour et al., 2011). In health-care 
environments, a variety of surfaces, including tabletops, bed rails, sinks, door handles, floors, 
mattresses, and pillows are implicated as potential sources of A. baumannii (Wilks et al., 2006; 
Karageorgopoulos and Falagas, 2008). It was reported that the use of contaminated medical 
devices such as catheters, sutures, ventilators can also serve as A. baumannii sources in hospitals 
(Montefour et al., 2008; Rao et al., 2008; Lee et al., 2008), and lead to subsequent colonization 
of the organism in the respiratory tract, blood, pleural fluid, urinary tract, surgical wounds, skin 
and eyes of patients (Bayuga et al., 2002; Gusten et al., 2002; Lorente et al., 2004). Thus the 
persistence of A. baumannii in the hospital environment is regarded as the most important factor 
aiding in the transmission of infection in nursing homes and nosocomial settings (Denton et al., 
2005; Rastogi et al., 2007; Karageorgopoulos and Falagas, 2008). 
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4. Pathogenicity of Acinetobacter infections and virulence 
The pathogenesis of A. baumannii infections is not completely understood, and hence the 
mechanisms involved in its colonization, infection and systemic spread are yet to be fully 
elucidated. A number of putative mechanisms having specific roles in colonization, infection and 
epidemic spread have been illustrated. These mechanisms include adherence to host cells, 
resistance to desiccation, disinfectants, and antibiotics, biofilm formation, quorum sensing, and 
elicitation of inflammatory responses and cytotoxicity (Dijkshoorn et al., 2007).  
Bacterial adherence to epithelial cells is a critical initial step in the process of 
colonization and infection (Beachey, 1981). The study conducted by Choi et al. (2008) found 
that A. baumannii has the potential to invade epithelial cells and its invasion of cells varies with 
the type of host cells. It was observed that respiratory tract epithelial cells were the most 
susceptible to invasion by A. baumannii compared to other epithelial cells. The various known 
virulence factors potentially contributing to A. baumannii pathogenesis are discussed below. 
4.1. Cell surface hydrophobicity and enzymes 
A. baumannii possesses significant cell hydrophobicity, which helps it adhere to host 
cells and evade phagocytosis, besides helping in successful attachment to plastic or polymer 
surfaces such as catheters (Doughari et al., 2011). The presence of a rough cell surface and 
protein protrusion on the surface of Acinetobacter reportedly confers hydrophobicity (Phuong et 
al., 2009; Rosenberg et al., 1980). In addition, cell surface enzymes have been found to influence 
the hydrophobicity in A. baumannii. Boujaafar et al. (1990) observed that A. baumannii isolates 




4.2. Toxic slime polysaccharides 
The production of toxic slime polysaccharides in Acinetobacter spp. have been reported 
by Hoštacká (2002). These polysaccharides are composed of glucose building blocks, glucuronic 
acid, D-mannose, L-ramnose and D-glucose, which are produced during the exponential stage of 
A. baumannii growth. Besides exerting a toxic effect on neutrophils, the slime inhibits their 
migration and phagocytosis. Moreover, capsular polysaccharides produced by A. baumannii help 
the bacterium in evading the host immune response, and growing in serum (Russo et al., 2011). 
In general, slime producing Acinetobacter strains have been found to be more virulent than non-
producers (Obana, 1986). 
4.3. Outer membrane protein 
Outer membrane proteins (Omp) play an important in the pathogenesis of many Gram-
negative bacteria. Outer membrane protein A (OmpA, 38 kDa) has been identified in several 
strains of Acinetobacter, especially A. baumannii (Dijkshoorn, et al., 2007; Gordon and 
Wareham, 2010). During infection, A. baumannii OmpA binds to eukaryotic cells and 
subsequently gets translocated into the nucleus, causing cell death (Dorsey et al., 2003; 
Dijkshoorn et al., 2007; Choi et al., 2008). It was also shown that OmpA of A. baumannii 
induces early onset of apoptosis and delays necrosis in dendritic cells.  In addition, OmpA has 
been reported to play a role in biofilm formation, surface motility and serum resistance in A. 
baumannii (McConnell et al., 2013). Besides OmpA, Omp33-36 is another outer membrane protein 
shown to be critical for A. baumannii virulence by inducing apoptosis of host cells by activation 
of caspases and modulation of autophagy (Rumbo et al., 2014). In addition, cell surface 
components such as adhesins and fimbriae (pili) have been reported to play a role in A. 
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baumannii attachment to host cell as well as inanimate surfaces (Smith et al., 2007; Braun, 2008; 
Musafer and Essa, 2013; Eijkelkamp et al., 2013). 
4.4. Surface and mitochondrial porins 
Porins are proteins that form channels enabling the transport of molecules across the lipid 
bilayer membrane of bacterial cells. Depending upon the bacterial species, porins play an 
important role in the maintenance of cellular structural integrity, bacterial conjugation, 
bacteriophage binding and antimicrobial resistance (Vaara et al., 1992). Moreover, pore 
formation facilitates the passage of small molecules into the bacterial cell (Braun, 2008). Pores 
as outer membrane structures, are an important part of efflux pumps, thereby aiding in the 
exclusion of toxic materials from the cell. Vila et al. (2007) indicated that porins in A. baumannii 
coupled with efflux pumps create an important barrier for the uptake of antibiotics. 
4.5. Siderophores 
The capacity of a bacterium to acquire iron for its growth in a host is considered as a 
critical virulence determinant. Siderophores are host iron-binding proteins which assist in iron 
uptake by the producing bacteria. Acinetobacter siderophores are called as acinetobactins 
(Mihara et al., 2004). Acinetobacters are capable of synthesizing siderophores, which can 
convert polymeric ferric oxy-hydroxides to soluble iron chelates under low iron stress (Neilands, 
1995). A. baumannii can acquire ferric ions under limited iron conditions through siderophores, 
and this is reported to play a critical role in its virulence. Gaddy et al. (2012) observed that 
acinetobactin mediated iron acquisition system in A. baumannii resulted in human epithelial cell 
damage and mortality in Galleria mellonella caterpillars and infected mice. Further, clinical 
strains of A. baumannii have been found to grow under iron deficient conditions, and were 
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shown to excrete an iron-regulated catechol siderophore into culture supernatants (Echenique et 
al., 1992; Actis et al., 1993). 
In addition to the aforementioned virulence factors, a variety of enzymes produced by A. 
baumannii have been reported to a play role in its virulence. For example, mutants of A. 
baumannii in phopsholipases were found to possess decreased serum resistance and invasion of 
host cells, and reduced pathogenesis in a murine model of pneumonia (Jacobs et al., 2010; Stahl 
et al., 2015). Similarly, enzymes such as butyrate esterase, caprylate esterase, and leucine 
arylamidase are believed to be involved in the hydrolysis of short chain fatty acids, thereby 
causing damage to host tissue lipids (Jolly-Guillou and Brun Buisson, 1996; Rathinavelu et al., 
2003; Towner, 2006).  Besides these factors, biofilm formation and antibiotic resistance 
contribute to A. baumannii virulence. 
5. Biofilm Formation 
Biofilm is a complex material, composed of microorganisms attached to surfaces and 
enclosed in a hydrated polymeric matrix of three dimensional structures. The matrix comprises 
of polysaccharides, proteins and nucleic acids (Vidal et al., 1996; Costerton et al., 1999; Sauer et 
al., 2007). A. baumannii can persist for prolonged periods of time in the hospital environment in 
biofilms, thereby insulating it from disinfectants, and serving as a continuous source of infection. 
Besides increasing the potential for nosocomial spread, biofilm production in A. baumannii also 
contributes to antibiotic resistance. The adherence of A. baumannii to biotic and abiotic surfaces 
facilitates the development of biofilms, which is responsible for the persistence of the pathogen 
in medical settings as well as development of resistance to antibiotics (Donlan and Costerton, 
2002; Gaddy and Actis, 2009). The major factors that regulate biofilm synthesis in A. baumannii 
include nutrient availability, surface structures such as pili, outer membrane proteins, quorum 
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sensing, and macromolecular substances such as DNA and  polysaccharides (Gaddy and Actis, 
2009; Cerqueira and Peleg, 2011).  
A. baumannii pili are encoded by the csu/BABCDE chaperone-usher assembly system, 
which is controlled by a two-component regulatory system encoded by bfmS and bfmR 
(Cerqueira and Peleg, 2011; Luo et al., 2015). Transposon mutagenesis revealed that csuA and 
csuE are critical for bacterial attachment, biofilm production and pili synthesis (Tomoaras et al., 
2003). Subsequent research by the same researchers indicated that inactivation of bfmR response 
regulator led to absence of csu expression, with a lack of pili production and biofilm formation in 
A. baumannii. However, mutation in bfmS was found to impair biofilm synthesis only partially.  
Another surface protein called biofilm-associated protein (Bap) is also associated with biofilm 
production in A. baumannii; mutation of this gene reduced biofilm thickness by more than 50% 
compared to wild type (Loehfelm, 2008). Similarly, OmpA has been found to be critical for 
forming thick biofilms, especially on polystyrene surface (Gaddy et al., 2009). In addition, 
exopolysaccharides, particularly poly-β-(1-6)-N-acetylglucosamine (PNAG) have been reported 
to be necessary for the integrity of A. baumannii biofilms formed under dynamic and stressful 
environments (Choi et al., 2009). Further, PNAG is believed to play a role in cell-to-cell 
adhesion (Cramton et al., 1999). Besides the aforementioned factors, quorum sensing, a well-
studied cell-to-cell communication mechanism in bacteria, has also been observed to regulate 
biofilm synthesis in A. baumannii. The quorum sensing molecule, 3-hydroxy-C12-HSL, encoded 
by the autoinducer synthase gene, abaI is critical for later stages of biofilm production, 
especially on abiotic surfaces (Niu et al., 2008). 
Several researchers have observed that the clinical isolates of A. baumannii are found to 
be strong biofilm formers (Rodriguez-Baño et al., 2008; King et al., 2009; Eijkelkamp et al., 
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2011; Gurung et al., 2013). Besides increasing the potential for nosocomial spread, biofilm 
production in A. baumannii contributes to antibiotic resistance and increased virulence. For 
example, clinical isolates of MDR A. baumannii demonstrated a strong ability to produce 
biofilms, which correlated to increased attachment to human bronchial epithelial cells (Lee et al., 
2008; Rao et al., 2008; Shin et al., 2009; Gordon et al., 2010). Therefore, inhibiting biofilm 
production in A. baumannii is crucial for controlling its transmission in hospitals as well as 
reducing its antibiotic resistance and virulence.  
6. Clinical manifestations of A. baumannii infections 
Being an opportunistic pathogen, A.baumannii generally affects critically ill patients in 
intensive care units (ICUs), specifically those depended on mechanical ventilation or in patients 
with wound or burn injuries. It causes infections like ventilator-associated pneumonia, skin and 
soft-tissue wound infections, urinary tract infections, peritonitis, secondary meningitis and 
bloodstream infections (Bergogne-Bérézin and Towner, 1996; Peleg et al., 2008). The major risk 
factors that predispose to A. baumannii infection include prolonged period of hospitalization, 
residence in an intensive care unit, receipt of mechanical ventilation, use of central venous or 
urinary catheters, exposure to broad-spectrum antimicrobial agents, recent surgery, invasive 
procedures, and underlying disease conditions (Saulnier et al., 2001; Fournier et al., 2006; 
Playford et al., 2007; Montefour et al., 2008). However, the persistence of A. baumannii in the 
hospital environment is the most important factor aiding in the transmission of infection in 
nursing homes and nosocomial settings (Simor et al., 2002; Denton et al., 2005; Rastogi et al., 
2007).  In addition, community-acquired A. baumannii pneumonia Guner et al., 2011; Silva et 
al., 2012), bacteremia (Obaro et al., 2011), urinary tract infection (Solak et al., 2011), and 
meningitis (Ozaki et al., 2009) have been reported.  
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Hospital acquired pneumonia was reported to be 15% of all nosocomial infections, with 
A. baumannii being considered as an important pathogen associated with high mortality in 
patients suffering from pneumonia (Fagon et al., 1989; Timsit et al., 1996). A report from the 
Centers for Disease Control and Prevention (CDC) showed that the percentage of incidence of 
Acinetobacter-associated ICU-acquired pneumonia increased from 4% in 1986 to 7% in 2003 
(Gaynes and Edwards, 2005). This is of concern especially in immunocompromised patients 
admitted to ICUs and in surgical wards. The high incidence of hospital-acquired pneumonia is 
attributed to the use of A. baumannii contaminated ventilators and endotracheal tubes (Cefai et 
al., 1990; Bernards et al., 2004). Pneumonia caused by Acinetobacter are similar to those caused 
by Gram-negative bacteria, with symptoms such as fever, leukocytosis, purulent sputum 
production and appearance of new infiltrates on radiograph or CT scan. Further, the pathogen 
could be isolated from bronchial brushings (Chaste et al., 1996).  
A. baumannii has been reported as the tenth most common etiologic agent causing 
nosocomial ICU-acquired bloodstream infections (BSI) in the United States (Wisplinghoff, 
2000).  The overall mortality from A. baumannii BSIs ranges from 34 to 43% in the ICU and 
16% in patients outside the ICU (Peleg et al., 2008). In a study investigating the clinical and 
epidemiological features of nosocomial BSIs caused by Acinetobacter species at 49 US hospitals 
during the period from March 1995 through February 1998, Wisplingoff et al. (2000) reported 
that Acinetobacter species were found in 24 hospitals (49%) accounting for 1.5% of all 
nosocomial BSIs. Of the 129 Acinetobacter isolates, 111 were A. baumannii and 18 belonged to 
other Acinetobacter species.  In addition, 30% of the isolates were resistant to multiple 
antibiotics. A report from South Korea indicated that A. baumannii was responsible for 112 cases 
of bacteremia in patients, whereas other Acinetobacter species such as A. lwoffii, A. 
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haemolyticus, and A. calcoaceticus were the causative agents of BSI in 28 patients (Choi et al., 
2006). 
Although A. baumannii rarely causes meningitis in community settings, it is increasingly 
reported to be associated with post-neurosurgical meningitis, especially with mortality rates as 
high as 64% (Garcia-Garmendia et al., 2001). In a study involving 281 adult patients with 
nosocomial bacterial meningitis, 3.6% were diagnosed with Acinetobacter spp. meningitis (Kim 
et al., 2009).  Likewise, two studies from Turkey reported Acinetobacter spp. as the leading 
cause of Gram-negative post-neurosurgical meningitis (Sacar et al., 2006; Metan et al., 2007).  
Frequent distribution of Acinetobacter species on human skin has been reported to 
predispose infections involving skin and soft tissues (Seifert et al., 1997). A. baumannii was 
found responsible for 2.1% of ICU–acquired skin/soft tissue infections (Gaynes and Edwards, 
2005). A. baumannii was also isolated from wounds of combat casualties from Iraq and 
Afghanistan (Scott et al., 2007; Murray and Hospenthal, 2008; Peleg et al., 2008). In addition, A. 
baumannii is associated with persistent wound infections in burn victims with delayed wound 
healing (Bergogne-Berezin, 1995; Santucci et al., 2003; Sharma, 2007).Besides the above 
conditions, A. baumannii has been implicated in catheter-associated urinary tract infections 
(Gaynes and Edwards, 2005), endocarditis (Olut and Erkek, 2005; Menon et al., 2006), and eye 
infections (Kau et al., 2002; Levy et al., 2005). 
7. Antibiotic resistance 
Acinetobacter is considered multi-drug resistant (MDR) if it is resistant to at least three 
classes of antimicrobial agents. A.baumannii has emerged into a MDR bacterium difficult to treat 
due to its resistance to most of the currently available antibiotics. In fact, it is often viewed as the 
most difficult antimicrobial-resistant Gram-negative bacillus to control and treat (Maragakis and 
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Perl, 2008). Carbapenems were once the first choice antibiotics for treating A. baumannii, but are 
no longer completely effective due to resistance development by the bacterium (Falagas and 
Karaveli 2007; Bassetti et al., 2008). Similarly, polymyxins were successfully used to treat A. 
baumannii infections a few years ago, however, strains resistant to these drugs have also evolved 
(Hernan et al., 2009). Thus, the resistance of A. baumannii to multiple antibiotics presents a great 
challenge for health-care professionals for controlling infections associated with this pathogen.   
A. baumannii possesses a variety of antibacterial resistance mechanisms. These 
mechanisms include intrinsic and extrinsic ones, and multiple factors are reported to favour the 
acquisition of multidrug-resistance in A. baumannii (Vila and Pachon, 2008). These include the 
ability of the bacterium to persist in environmental and human reservoirs, which aids in the 
transfer of genetic materials between other microorganisms and A. baumannii, capacity to 
acquire a wide variety of genetic elements, including plasmids, transposons and integrons (Vila 
and Pachon, 2008).  
Besides the intrinsic mechanisms conferring resistance to aminopenicillins, 
cephalosporins and chloramphenicol, A. baumannii has acquired mechanisms that impart 
resistance to β-lactam antibiotics, aminoglycosides, tetracyclines and fluoroquinolones 
(Dijkshoorn, et al., 2007). In addition, expression of β-lactam hydrolyzing enzymes, induced 
changes in the outer membrane proteins, up-regulation of multiple drug efflux pumps, altered 
penicillin binding proteins (PBP), antibiotic modifying enzymes, machineries for modification of 
antibiotic target binding sites, ribosomal protection, and porin channel deletions have also been 
reported in A. baumannii (Gordon and Wareham., 2010).  
The transportation of antimicrobial agents into the bacterial cell and their subsequent 
effect are controlled by porin channels and other outer membrane proteins in bacteria. The lack 
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of these outer membrane proteins and channels, thus preventing antimicrobials from reaching 
their targets resulting in resistance has been reported in Acinetobacter spp. (Thomson and 
Bonomo, 2005; Bou et al 2000; Mussi et al., 2005).  Li et al. (2005) reported the development of 
colistin resistance in Acinetobacter due to changes in the bacterial membrane that hinder the 
action of the antibiotic on the bacterial targets.  In addition, the efflux pumps which aid 
Acinetobacter spp. in the removal of antimicrobial agents from bacterial cells have been 
observed (Bonomo and Szabo, 2006). The efflux pumps are membranes embedded proteins 
which function by excluding the antibiotic out of the cell. The reported efflux pump systems 
include AdeABC (Magnet et al., 2001), AdeIJK (Damier-Piolle et al., 2008), AdeXYZ (Roca et 
al., 2011), AdeM (Su et al., 2005),Tet(A) and Tet(B) (Guardabassi et al., 2000; Ribera et al., 
2003a; Ribera et al., 2003b). Schaack et al. (2010) reported that the over expression of AdeABC 
efflux pump causes resistance to cephalosporins, fluoroquinolones, and tigecycline. AbeM efflux 
pump confers resistance aminoglycoside and fluoroquinolone (Gootz and Marra, 2008), whereas 
Tet(A) and Tet(B) and CmlA encode for resistance to tetracyclines and chloramphenicols, 
respectively (Bergogne-Berezin et al., 2008).  
Exceeding 50 different degrading enzymes or their allelic forms have been found to 
confer resistance to β–lactam antibiotics, including extended spectrum β-lactamases, 
oxacillinases and metallo-β-lactamases (Bergogne-Be’re’zini and Towner., 1996). These 
multiple β-lactamases confer resistance to different classes of β-lactam antibiotics such as 
penicillin derivatives, cephalosporins and carbapenems in A. baumannii. The various classes of 
β-lactamases include class A β-lactamases (Nagano et al., 2004; alNaiemi et al.,2005; Pasteran et 
al., 2006), class B β-lactamases (metallo β-lactamases) (Chu et al., 2001;Lee et al.,2003; 2005), 
class C β-lactamases (eg. Acinetobacter-derived cephalosporinases or the chromosomally-
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encoded AmpC enzymes) (Bou et al 2000) and class D β-lactamases responsible for resistance of 
carbapenems through the production of oxacillinases (Peleg et al., 2008). In addition, class A 
extended spectrum beta lactamases (ESBLs) are also present in A. baumannii (Vila et al., 1993). 
Additionally, the presence of PER-1, an ESBL in A. baumannii which imparts a high level of 
resistance to penicillins and extended-spectrum cephalosporins, but not to carbapenems has been 
detected (Yong et al., 2003; Sechi et al., 2004; Farajnia et al., 2013). 
A few Acinetobacter species expressing VIM and IMP β-lactamases capable of 
hydrolyzing different antimicrobial agents, including carbapenems have been detected (Thomson 
and Bonomo, 2005).  Researchers commented that since the metallo-β-lactamases are located on 
mobile genetic elements, the potential for their transfer from one bacterium to another is high 
(Thomson and Bonomo, 2005; Bonomo and Szabo, 2006). AmpC cephalosporinases which come 
under class C β-lactamases are chromosomally encoded and confer resistance to broad-spectrum 
cephalosporins (Thomson and Bonomo, 2005; Bonomo and Szabo, 2006).  Similarly, class D 
OXA type enzymes (β-lactamases with carbapenem-hydrolysing properties) were also reported 
in A. baumannii from various countries (Brown and Amyes, 2006; Afzal-Shah et al., 1999; 
Opazo et al., 2011; 2012). 
 Resistance to aminoglycoside antibiotics through their modification by integron-
associated or plasmid-encoded genes, which encode acetyltransferases, nucleotidyltransferases 
and phosphotransferases is documented in MDR A. baumannii. Moreover, 16S rRNA 
methylation causing impaired binding of gentamicin, tobramycin and amikacin to their target 
sites, thereby leading to their resistance is documented (Beceiro et al., 2013). Besides these 
machineries, gentamicin and kanamycin can be effluxed out by AbeM efflux pump in A. 
baumannii (Vila et al., 2007). Mutations in gyrA and parC resulting in the modification of DNA 
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gyrase or topoisomerase IV is the major underlying mechanism for quinolone resistance in A. 
baumannii (Park et al., 2011). Chromosomal mutations in the quinolone resistance determining 
region (QRDR) of the  gyrA and parC, and resulting production of  modified bacterial DNA 
gyrase and topoisomerase IV enzymes has been reported to confer resistance to quinolones in A. 
baumannii (Peleg et al., 2008). A decreased influx and/or increased efflux of quinolones can also 
contribute to quinolone resistance (Peleg et al., 2008). However, as an adjunct, involvement of 
AdeABC and AdeM pumps also play a role in quinolone resistance (Chopra and Galande., 
2011).  
8. Plant-derived antimicrobials 
Plant-derived antimicrobials (PDAs) are secondary metabolites produced by plants 
possessing potential antibacterial activity against a wide range of microbial pathogens and food 
spoilage bacteria (Burt, 2004; Holley and Patel; 2005; Upadhyay et al., 2014). These secondary 
metabolites are generally aromatic compounds comprising alkaloids, glycosides, terpenoids, 
saponins, steroids, flavonoids, tannins, quinones and coumarins (Das et al., 2010). A majority of 
these compounds are produced by plants as a defence mechanism against by microorganisms and 
insects (Cowan, 1999). In many cultures, PDAs have been used as dietary constituents and 
ingredients in herbal and traditional medicines (Wollenweber and Kinzel, 1988). The general 
mechanisms of antimicrobial effect of PDAs include increasing permeability of the bacterial 
membrane, disintegration of bacterial cytoplasmic membrane, and destabilization of the proton 
motive force, electron flow, active transport and coagulation of the cell content (Burt, 2004). 
Trans-cinnamaldehyde (TC) is an aldehyde present in the bark extract of cinnamon. 
Trans-cinnamaldehyde has a wide margin of safety between conservative estimates of intake, 
with no observed adverse effects, including genotoxic and mutagenic effects from sub chronic 
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and chronic studies (Adams et al., 2004). Trans-cinnamaldehyde possesses antimicrobial activity 
towards a wide range of Gram-positive and Gram-negative bacteria (Bowles and Miller, 1993; 
Bowles et al., 1995; Friedman et al., 2002). Besides the deleterious effect exerted on the bacterial 
membrane, TC acts by depleting intracellular ATP by inhibiting ATPase supported energy 
metabolism along with inhibition of glucose uptake and its utilization (Gill and Holley,2004; 
Oussalah et al.,2006; Negi, 2012). Eugenol (EG) is a natural molecule present as an active 
ingredient in the oil from cloves (Eugenia caryophillis) (Ali et al., 2005; Yadav et al., 2013). The 
antibacterial activity of clove oil and eugenol has been documented by many researchers (Menon 
and Garg, 2001; Hyldgaard et al., 2012). Eugenol has been found to cause cell wall degradation 
and cell lysis in bacteria (Thoroski, 1989). Both TC and EG are classified as GRAS by the FDA 
(TC, 21 CFR 182.60 (CFR, 2011a); EG, 21 CFR 582.60 (CFR, 2011b). 
Although considerable amount of literature exists on the antimicrobial properties of 
several PDAs on a wide range of microorganisms, comparatively limited information is available 
on their effect on bacterial antibiotic resistance, especially in Gram-negative pathogens. A 
handful of studies have revealed that PDAs could be used to potentiate the effect of antibiotics in 
bacteria. Previously, Chusri et al. (2009) observed that two plant molecules, ellagic acid and 
tannic acid when used as adjuvants enhanced the antimicrobial activity of several antibiotics 
against A. baumannii. These investigators reported that ellagic and tannic acids at 40 µM, 
increased the activity of novobiocin, coumermycin, chlorobiocin, rifampicin and fusidic acid 
against A. baumannii. Likewise, Duarte et al. (2012) reported that the essential oil from coriander 
exerted synergistic or additive effects with antibiotics such as tetracycline, chloroamphenicol, 
ciprofloxacin, gentamicin, piperacillin and cefoperazone against A. baumannii. In addition, a 
recent study by Saghi et al. (2015) reported that the essential oil from Origanum vulgare 
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possessed potent antimicrobial activity against MDR A. baumannii. In yet another study, 
Kollanoor-Johny et al. (2010) reported that sub-inhibitory concentrations of several PDAs, 
including TC and EG decreased antibiotic resistance (P < 0.05) in MDR S. Typhimurium DT 
104. Follow up mechanistic studies using RT-qPCR revealed that TC decreased antibiotic 
resistance in DT 104 by down-regulating several antibiotic resistance genes. 
In Gram-positive bacteria, Blanco et al. (2005) reported that epigallocatechin-gallate, an 
ingredient in green tea, neutralized tetracycline resistance in Staphylococcus aureus by inhibiting 
the efflux pump, TetK. Similarly, biacalein, a flavalone present in thyme extract potentiated the 
effect of tetracyclines and β-lactams on methicillin-resistant S. aureus (Fujita et al., 2005). In 
another study, two ingredients in the medicinal plant Berberis, namely berberine and 5’-
methoxyhydnocarpin, inhibited the multi-drug efflux pump, NorA in S. aureus (Sternmitz et al., 
2000).  Likewise, TC was reported to reduce clindamycin resistance in the human pathogen, 
Clostridium difficile (Shahverdi et al., 2007).  
9. Summary 
Being ubiquitous in distribution, A. baumannii has been isolated from soil, water and a 
variety of foods, including fruits and vegetables, thereby raising concerns that fresh produce 
could be a potential source of infection to humans, particularly in health-care settings. In 
addition, the isolation of genotypically similar strains of Acinetobacter from food, environment 
and clinical specimens further underscores the concerns on the role of food and water as 
potential sources of human infections. Being resistant to most of the currently available 
antibiotics, identification of effective antimicrobials or molecules that potentiate the efficacy of 
antibiotics against A. baumannii is critical for controlling infections caused by this bacterium. 
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Based on published literature and preliminary research conducted in our laboratory, it 
was hypothesized that MDR A. baumannii is potentially present on fresh vegetables, and 
chlorine is ineffective as a water disinfectant forkilling the bacterium. In addition, it was 
hypothesized that TC and EG reduce antibiotic resistance and virulence in A. baumannii, and 
may be useful in treating wound infections caused by the bacterium.  
The specific objectives of this dissertation were 
1: To investigate the prevalence of MDR A. baumannii on fresh vegetables collected from 
farmers’ market in Connecticut. 
2: To determine the effect of chlorine on A. baumannii survival in water and expression of its 
antibiotic resistance genes 
3: To develop a real-time quantitative PCR for specific detection of A. baumannii in water and 
blood. 
4: To determine the effect of TC and EG on decreasing A. baumannii resistance to β-lactam 
antibiotics. 
5: To investigate the efficacy of TC and EG in reducing A. baumannii adhesion to and invasion 
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This study determined the prevalence of multidrug resistant (MDR) A. baumannii on fresh 
vegetables collected from farmers’ markets in Connecticut. One hundred samples each of fresh 
carrots, potatoes and lettuce were collected during the period 2012-13 for one year. The 
vegetables were sampled and streaked on selective media, namely Leeds Acinetobacter and 
MDR Acinetobacter agars.  All morphologically distinct colonies from MDR Acinetobacter agar 
were identified using Gram staining, biochemical tests and polymerase chain reaction. In 
addition, susceptibility of the isolates to ten commonly used antibiotics in humans, namely 
imipenem, ceftriaxone, cefepime, minocycline, erythromycin, colistin-sulphate, streptomycin, 
neomycin, doxycycline, rifampcin was determined using antibiotic disc diffusion assay. The 
results revealed that out of 100 samples of each vegetable tested, only two samples of potato and 
one sample of lettuce yielded A. baumannii. No carrot sample was found to be positive for A. 
baumannii. However, several other opportunistic, MDR human pathogens such as Burkholderia 
cepacia (1% potatoes, 5% carrots and none from lettuce), Stenotrophomonas maltophilia (6% 
potatoes, 2% lettuce and none in carrots) and Pseudomonas luteola (9% potato, 3% carrot and 
none in lettuce) were recovered from the vegetables. Antibiotic susceptibility screening of the 
isolates revealed high resistance rates for ceftriaxone (100%), colistin-sulphate (83%), 
erythromycin (83%) and streptomycin (66%) in B. cepacia; for colistin-sulphate (100 %) and 
imipenem (90%) in P.luteola; for colistin-sulphate (100%), ceftriaxone (100%), cefepime (87%), 
erythromycin (62%) and imipenem (50%) in S. maltophilia, and for imipenem (100%), 
ceftriaxone (100%), erythromycin (100%) and streptomycin (100%) in A. baumannii. The results 
revealed the presence of MDR bacteria, including human pathogens on fresh produce, thereby 
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Acinetobacter baumannii, a Gram-negative, aerobic, opportunistic bacterial pathogen, 
which has emerged as one of the most problematic bacteria to treat due to its resistance to most 
of the commonly used antibiotics (Fishbain and  Peleg. 2010;Moradi et al., 2015). A. baumannii 
has been reported as the most common multi-drug resistant (MDR) pathogenic bacterium 
involved in hospital-acquired infections, particularly intensive care units (Dijkshoorn et al., 
2007; Marti et al., 2011) causing mortality rates ranging from 34 to 61% (Esterly et al., 2011). In 
addition, A. baumannii is capable of causing a wide spectrum of infections in humans, including 
ventilator associated pneumonia, bacteremia and meningitis (Joshi et al., 2006; Maragakis and 
Perl; 2008; Manchanda et al., 2010; Guner et al., 2011; Solak et al., 2011). Acinetobacter spp. 
isfrequently isolated from soil and water (Baumann, 1968; Warskow and Juni, 1972; Eliopoulos, 
2008; Krizova, 2014), which are considered to be their major habitats. Acinetobacter was 
reported to be present at a level of 38% in ground water samples (Bifulco et al., 1989), with 
isolation from water systems in multiple parts of the world (Ferreira et al., 2011; Zhang et al., 
2013). Moreover, protozoans such as Acanthamoeba were found to support the growth of A. 
baumannii, and act as its reservoir in water (Cateau et al., 2011). In addition, Acinetobacter spp., 
including A. baumannii, have been isolated from other sources such as foods, arthropods, 
animals and humans (Baumann, 1968; Berlau et al., 1999; Mussi et al., 2005; Fournier and 
Richet, 2006; Munoz-Price and Weinstein, 2008). Although a few investigations conducted 
overseas have isolated A. baumannii and other Acinetobacter spp. from a variety of fresh 
produce, no extensive studies have been undertaken in the United States. 
          During the last decade, there has been an increased in the demand for local and regional 
food products, especially fresh produce because of their perceived freshness and quality, which 
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is believed to be due to a shorter period of time elapsed between harvesting and selling. 
According to the USDA’s Agricultural Marketing Service, there has been a rise in the number 
and popularity of farmers’ markets over the years in the United States, with an increase in 
number from 1,755 in 1994 to 8,284 in 2014 (USDA-ERS, 2014). However, relatively scant 
information exists on the microbiological safety and quality of fresh produce sold at farmers’ 
markets as against retail sold produce. In addition, concerns exist about the storage conditions of 
the produce displayed throughout the day, the farming practices adopted by the farmers, and the 
pre- and post-harvest handling techniques employed (Kader and Rolle, 2004). A study conducted 
on the microbiological safety and quality of herbs sold at farmers’ markets in Los Angeles, 
Orange county and Seattle revealed the presence of Salmonella and generic Escherichia coli, 
although the sources and extent of contamination were not reported (Levy et al., 2014). Another 
study compared the microbial populations in lettuce and spinach obtained from grocery stores 
and farmers’ markets in Indiana, and reported greater bacterial (mesophilic plate count), yeast 
and mold contamination on lettuce from farmers’ markets (Soendjojo, 2012).  A study conducted 
in Germany revealed that vegetables from farmers’ markets contained more antibiotic resistance 
bacteria when compared to those sold at retail stores (Schwaiger et al., 2011). The same 
researchers suggested that since vegetables from farmers’ markets are not usually cooled or 
washed with antimicrobials, the bacteria present have greater chances of carrying and expressing 
antibiotic resistance genes (Schwaiger et al., 2011) as exposure of bacteria to stresses such as 
low temperature was found to lower the MIC of antimicrobials as compared to unstressed 
controls (McMahon et al., 2007). In a recent study conducted in British Columbia, Canada, 
Wood et al. (2015) tested lettuce (n = 68) collected from five farmers’ markets, and found that 
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13% of the samples contained E. coli, and 97% of the E. coli isolates displayed resistance to one 
or more antimicrobials. 
The objective of this study was to determine the prevalence of MDR A. baumannii in 
fresh vegetables, specifically carrots, lettuce and potatoes collected from farmers’ markets in 
Connecticut. 
2. MATERIALS AND METHODS 
2.1. Sample collection and detection of Acinetobacter spp. 
The prevalence rate of A. baumannii in vegetables reported in the literature ranges from 17% 
(Berlau et al., 1999) to 50% (Houang et al., 2001). Based on a conservative 5% prevalence rate, 
we conducted a power analysis using the probability theory (Snedecor and Cochran, 1967) to 
determine the number of vegetable samples required for isolating A. baumannii with a 
confidence level of 95%. Based on the power analysis results, a total of 100 samples each of 
fresh potatoes, carrots and lettuce were procured from 55 farms distributed over 15 farmers’ 
markets in various counties in Connecticut. All the vegetables were sold loose and unprocessed, 
and were randomly purchased from different vegetable stands. All samples were immediately 
brought to the laboratory on ice, and processed within 8 h of collection. The sample collection 
was made during the period 2012-13 for one year covering two successive cropping seasons. For 
the detection of A. baumannii, approximately fifty grams of each sample was shaken vigorously 
in 450 ml sterile Tryptic soy broth (TSB) in a Whirlpak bag (Nasco, Fort Atkinson, WI) for 2 
min. The samples were then streaked on selective media, namely Leeds Acinetobacter medium 
and MDR Acinetobacter medium (Hardy Diagnostics, Santa Maria, CA), which have been used 
to isolate Acinetobacter spp. from both clinical and environmental samples (Jawad et al., 1994). 
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In addition, the enrichment samples in TSB were incubated at 37oC for 24 h and streaked again 
on Leeds and MDR Acinetobacter media. The plates were incubated at 37oC for 24 h. 
2.2. Identification and Characterization of the Isolates 
All morphologically different colonies from MDR Acinetobacter medium were first subjected to 
Gram staining, followed by presumptive identification by biochemical tests using API 20 NE 
(bioMérieux, Cambridge, MA), which assays for 61 Gram-negative bacteria (Chang et al., 2005; 
Bosshard et al., 2006; Dortet et al., 2006). The manufacturers’ instructions were followed for 
performing the biochemical tests. Each biochemical test well was inoculated with an overnight 
(0.5 McFarland) bacterial suspension, followed by incubation at 37oC. The tests results were read 
after 24 and 48 h, and the interpretation of the results was done using the identification software 
version 6.0 (bioMérieux, Cambridge, MA). All the cultures were also subjected to oxidase test to 
compliment the biochemical tests in API 20 NE. Following identification by biochemical tests, 
the isolates were further confirmed by polymerase chain reaction (PCR) using 16s rRNA 
(Widmer et al., 1998; Clode et al., 1999; LiPuma et al., 1999; Whitby et al., 2000). The 
chromosomal DNA from each isolateextracted using InstaGene Matix (Bio-Rad, Hercules, CA) 
was used as a template for PCR. The primers tested for confirming the isolates are provided in 
Table1. The amplification of the 16S ribosomal RNA in each sample was performed in a 
thermocycler (PTC 100; MJ Research, Waltham, MA). PCR conditions were initial denaturation 
at 95oC for 5 min, followed by 40 cycles of denaturation at 94oC for 1 min, annealing at 55-62oC 
(depending on the target bacteria) for 30 s and extension at 72oC for 10 min. The resulting PCR 
amplicons were examined by gel electrophoresis and visualization by gel documentation system 
(Bio-Rad, Hercules, CA). 
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2.3. Antibiotic Susceptibility Testing 
          The susceptibility of the various isolates to 10 antibiotics was tested by disc diffusion 
method (NCCLS, 1999). The antibiotics screened included Imipenem (10 μg), Ceftriaxone (30 
μg), Cefepime (30 μg), Minocycline (30 μg), Erythromycin (15 μg), Colistin-sulphate (10 μg), 
Streptomycin (10 μg), Neomycin (30 μg), Doxycycline (30 μg), Rifampcin (5 μg) purchased 
from Oxoid (Hampshire, UK). All the cultures were incubated at 37oC for 24 h. The zone 
diameter around the discs was measured horizontally and vertically. 
3. RESULTS AND DISCUSSION 
Fresh produce constitutes the leading cause of foodborne illnesses when compared to 
other food products (Doyle and Erickson, 2008), and a report from the US Centers for Disease 
Control and Prevention indicated that ~ 46% of all foodborne illnesses are caused by 
contaminated produce (Painter et al., 2013). Several pre-harvest factors such as proximity or 
contact with soil, feces, use of improperly composted manure, contaminated irrigation water, 
wild and domestic carrier animals and farm workers potentially contribute to contamination of 
fresh produce with a variety of microorganisms (Beuchat, 1996; Beuchat and Scouten, 2002).  
Antibiotic usage in food animal production, and simultaneous presence of antibiotic resistant 
bacteria in manure leads to potential persistence of these bacteria in agricultural soil (Sarmah et 
al., 2006). Since microorganisms present in soil could be transferred to produce, fresh produce 
consumption is reported as a potential route of direct human exposure to soil bacteria (Marti et 
al., 2013). In addition, usage of antibiotics in plant agriculture and contamination of irrigation 
water with animal feces could also serve as potential sources of antibiotic resistant bacteriaon 
fresh produce (Holvoet et al., 2013). The presence of antibiotic resistant bacteria on fresh 
produce is a significant concern to public health because of the potential transfer of antibiotic 
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resistance determinants to the enteric flora in humans (Sommer et al., 2010; Schjorring and 
Krogfelt, 2011). Similarly, Falomir et al. (2010) indicated that the presence of antibiotic 
resistance determinants in normal flora and pathogenic microorganisms on fresh vegetables 
might contribute to horizontal spread of resistances between different isolates, species and 
genera. It was also suggested that antibiotic resistance genes on transferable elements such as 
plasmids facilitates rapid distribution of resistance determinants among bacteria (De la Cruz and 
Davies, 2000; Heuer and Smalla, 2007). Thus monitoring the prevalence of antibiotic resistant 
bacteria on fresh produce is critical for risk assessment and devising appropriate food safety 
interventions. 
          In this study, we determined the prevalence of MDR A. baumannii on fresh vegetables 
such as lettuce, carrots and potatoes, which are previously reported to harbor A. baumannii 
(Berlau et al., 1999; Falomir et al., 2010). All 100 samples each of potatoes, carrots and lettuce 
were found to yield colonies on Leeds Acinetobacter medium. In addition, 74% potatoes, 86% of 
carrots, 73% lettuce samples had colonies growing on MDR Acinetobacter agar. These isolates 
were characterized using API 20 NE biochemical tests and confirmed with PCR using specific 
16s rRNA primers. As observed in Table 2, out of the 100 samples of each vegetable tested, only 
two samples of potato and one sample of lettuce were found to be positive for A. baumannii. No 
carrot sample was positive for the pathogen. Previously, Berlau and colleagues (1999), while 
studying the prevalence of Acinetobacter in fresh produce in the United Kingdom, reported that 
17% of 177 samples tested positive for the bacteria, including A baumannii. These investigators 
observed that 56% of the Acinetobacter belonged to A.baumannii-A. calcoaceticus group, which 
were found on apple, melon, bean, cabbage, cauliflower, carrot, potato, radish, lettuce, 
cucumber, pepper, mushroom, and sweet corn.  In another study, Houang et al. (2001) isolated A. 
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baumannii and genomospecies 3 from 21 of 41 vegetable samples, 53 of 74 fish and meat 
samples and 22 of 60 soil samples. Similarly, Falomir et al. (2010) detected the presence of A. 
baumannii on fresh lettuce collected from a nursery in Valencia city, Spain, with a most probable 
number of >2400, where the bacterium was found to exhibit resistance to four different 
antibiotics, namely amoxicillin/clavulanic, ampicillin, chloramphenicol and nitrofurantoine.  In 
yet another study, Walia et al. (2013) reported the isolation of A. baumannii along with other 
Gram negative bacteria from ready-to-eat baby spinach collected from local retail supermarkets 
in Rochester, MI. The isolates showed maximum resistance to cefoxitin, ampicillin, 
chloramphenicol, ceftrizoxime and tetracycline (Walia et al., 2013). Moreover, the resistance 
was found to be transferable in the strains tested.(Walia et al., 2013). 
          Although, this study was intended to focus on A. baumannii, several other antibiotic 
resistant bacteria were isolated from the MDR Acinetobacter agar plates besides A. baumannii. 
The major bacteria isolated included Burkholderia cepacia, Stenotrophomonas maltophilia and 
Pseudomonas luteola. Although no lettuce samples tested positive for Burkhoderia, 1% of 
potatoes and 5% of carrots yielded B. cepacia. B. cepacia is a plant pathogen causing soft rot of 
onions (Govan et al., 1996); however, it is now considered an opportunistic human pathogen 
causing respiratory and urinary tract infections as well as bacteremia in humans (Hutchinson et 
al., 2004; Mahenthiralingam et al., 2008). In addition, 6% of potatoes and 2% of lettuce tested 
were found to harbor S. maltophilia. S. maltophilia is ubiquitously present in the environment, 
and is commonly found associated with the rhizosphere of plants such as potato, wheat and 
cucumber (Muder et al., 1996; Denton et al., 1998; Berg et al., 1999); however, the bacterium is 
increasingly recognized as a nosocomial and opportunistic pathogen in humans (Senol, 2004; 
Tan et al., 2008; Brooke, 2012), especially with intrinsic resistance to many broad spectrum 
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antibiotics (Clark et al.,2003; Wang et al.,2004; Meyer et al.,2006). In a study conducted by Berg 
et al. (1999), several isolates of S. maltophilia from rhizospheres of plants exhibited resistance to 
multiple antibiotics, including Imipenem. In the current study, we also isolated P. luteola in 9% 
of potatoes and 3% of carrots, with no lettuce samples testing positive for this pathogen. P. 
luteola, formerly Chryseomonas luteola, is a saprophyte and psychrotrophic bacterium that can 
be isolated from water, soil, damp environments and vegetables (Membre and Kubaczka, 1998; 
Doublet et al., 2010).  It is considered a rare pathogen, but is known to cause septicemia, 
meningitis and infections in humans, which are mainly attributed to the use of contaminated 
catheters and prostheses (Doublet et al., 2010).  
          All of the aforementioned bacterial isolates were screened for resistance to ten antibiotics, 
which included two drugs from five major classes of antibiotics commonly used in human 
medicine (Tice et al., 2004; Karageorgopoulos and Falagas, 2008). The antibiotic resistance 
profile of the aforementioned isolates is depicted in Table 3. All the isolates of A. baumannii 
were resistant to Imipenem (100%), Ceftriaxone (100%), Erythromycin (100%) and 
Streptomycin (100%); two of the isolates were resistant to Cefepime, Neomycin and 
Doxycycline, and one isolate showed resistance to Minocycline, Colistin-sulphate and 
Rifampcin. It is important to note that although the prevalence of A. baumannii on the vegetables 
was low, the isolates were highly resistant to the commonly used antibiotics such asImipenem, 
Ceftriaxone, Erythromycin and Streptomycin. In a previous study conducted by Falomir et al. 
(2010), A. baumannii isolated from vegetables were resistant to Amoxicillin/clavulanic, 
Ampicillin, Chloramphenicol and Nitrofurantoine. Similarly, all B. cepacia/ isolates were 
resistant to Ceftriaxone, and five isolates were resistant to Cefepime, Colistin-sulfate and 
Erythromycin. The isolates showed least or no resistance to Doxycycline, Neomycin and 
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Minocycline. While all the isolates of S. maltophilia showed resistance to Colistin-sulfate and 
Ceftriaxone, they were susceptible to Minocycline and Doxycycline. P. luteola isolates showed 
maximum resistance to Colistin-sulfate and Imipenem and least resistance to Doxycycline and 
Minocycline.  
          To conclude, while results of this study indicate a low prevalence of MDR A. baumannii 
on vegetables, the presence of other opportunistic, MDR pathogens represents a potential health 
hazard to consumers, especially for immune-compromised and convalescent people. It is also 
critical to note that the isolates possessed resistance to common clinically used antibiotics in 
humans. Although risk assessment studies on human exposure to antibiotic resistant 
bacteria through the consumption of meat (via undercooking or cross-contamination) are 
available (Presi et al., 2009; Depoorter et al., 2012), such information on fresh produce is sparse. 
Moreover, since majorities of fresh produce are generally consumed without being subjected to a 
terminal microbial killing step unlike animal food products, the potential risk for human 
exposure to antibiotic resistant bacteria is greater, thereby underscoring the significance of good 
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Table 1. List of primers used in confirming bacteria isolated from vegetables from Farmers 
markets 
Bacteria                                           Primer sequence Size (bp)  
A. baumannii AB-R GACGATCTGTAGCGGGTCTG 
 
712  
 AB-F CCAGGTAAGGTTCTTCGCGT 
 Burkholderiaa RHG-F GGG ATT CAT TTC CTT AGT AAC 494 
 RHG-R GCG ATT ACT AGC CAT TCC AGA 
B. cepaciab PSR1 TTT CGA GCA CTC CCG CCT CTC AG 209 
 PSL1 AAC TAG TTG TTG GGG ATT CAT TTC 
Pseudomonasc PS-for GGT CTG AGA GGA TGA TCA GT 990 
 PS-rev TTA GCT CCA CCT CGC GGC 
P. luteolac PL- F AGA TGG ATT GGT GCC TTC GG 304 
 PL-R CAG ACT GCG ATC CGG ACT AC 
S. maltophiliad SM4 TTA AGC TTG CCA CGA ACA G 532 
 SM1 CAG CCT GCG AAA AGT A 
aLiPuma et al.,1999;; bClode et al., 1999; c Widmer et al., 1998; dWhitby et al., 2000 
 
Table 2. Prevalence of multi-drug resistant bacteria in vegetables from farmers’ markets in 
Connecticut  
Vegetable A.baumannii B.cepacia S.maltophilia P. luteola 
Potato(n = 100) 
(n=100) 
2 1 6 9 
Carrot(n=100) 
(n=100) 
0 5 0 3 
Lettuce (n=100) 
(n=100) 
1 0 2 0 
Total 3 6 8 11 
 
















Imipenem       
(10 mcg) 
100 33 50 90 
Ceftriaxone     
(30 mcg) 
100 100 100 82 
Cefepime        
(30 mcg) 
66 83 87 63 
 
Minocycline    
(30 mcg) 
33 0 0 27 
Doxycycline  
(30 mcg) 
66 16 0 9 
Colistin-sulfate 
(10 mcg) 
33 83 100 100 
Streptomycin  
(10 mcg) 
100 66 50 54 
Neo ycin       
(30 mcg) 
66 16 25 27. 
Erythromycin  
(15 mcg) 
100 83 62 63 
Rifa pcin         
(5 mcg 
















Effect of chlorine on A. baumannii survival in water and expression of antibiotic resistance 
genes 
 














Acinetobacter baumannii is a multi-drug resistant pathogen capable of causing a wide spectrum 
of clinical conditions in humans. Being ubiquitous in distribution, Acinetobacter spp. has been 
found in surface water, ground water, natural spring water and drinking water, thereby 
underscoring the significance of water disinfection to control human infections.  Chlorine is the 
most commonly used disinfectant in drinking and recreational water. Federal agencies, the CDC 
and EPA, recommend a maximum free chlorine level of 4 ppm in drinking water and 3 ppm in 
swimming water. This study investigated the effect of different levels of chlorine on the 
survivability of A. baumannii in water. Additionally, the effect of chlorine exposure on the 
transcription of genes conferring antibiotic resistance in A. baumannii was studied. Eight clinical 
isolates of A. baumannii, including a fatal meningitis isolate (ATCC 17978) at ~108 CFU/ml 
were separately exposed to different chlorine concentrations (0.2, 1, 2, 3 and 4 ppm) with a 
contact time of 30, 60, 90 and 120 sec. The surviving pathogen counts at each specified contact 
time were determined using broth dilution assay. In addition, real-time quantitative PCR (RT-
qPCR) analysis of the antibiotic resistance genes namely efflux pump genes (adeA, adeB, adeC, 
abeM), and those that code for resistance to antibiotics such as β-lactams (blaP), aminoglycoside 
(ami), sulfamethoxazole (sul1), tetracycline (tetA), and multiple drug resistance protein (mdrp), 
of three selected A. baumannii strains following exposure to chlorine was performed. Results 
revealed that all eight A. baumannii isolates survived the tested chlorine levels during all 
exposure times (P> 0.05). The RT-qPCR analysis revealed an up-regulation of all or some of the 
antibiotic resistance genes in the isolates, indicating a chlorine-associated induction of antibiotic 
resistance in the pathogen. Our results reveal that chlorine is not only ineffective in reducing A. 
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baumannii in water, but also induces the up-regulation of genes conferring resistance to multiple 
























          Multi-drug resistant (MDR) Acinetobacter baumannii is a major hospital-borne pathogen 
causing a wide spectrum of clinical conditions with significant mortality rates (Dijkshoorn et al., 
2007; Giamarellou., 2010; Perez et al., 2007; Karageorgopoulos et al.,2008; Peleg et al., 
2008;Martí, 2011).A. baumannii strains are equipped with a multitude of antibiotic resistance 
mechanisms rendering them resistant to most of the currently available antibiotics (Dijkshoorn et 
al., 2007; Karageorgopoulos et al.,2008). A. baumannii has a remarkable ability to persist for 
prolonged periods of time in the hospital environment in biofilms, thereby protecting it from the 
action of disinfectants, and serving as a continuous source of infection (Urban et al., 2003; 
Gaddy et al.,2009; Shin et al.,2009; Moultrie et al., 2011; Pour et al., 2011). In health-care 
environments, a variety of surfaces, including table tops, bed rails, sinks, door handles, floors, 
mattresses, and pillows have been implicated as potential sources of A. baumannii(Wilks et 
al.,2006; Karageorgopoulos et al., 2008;). 
          Water and soil are considered as a major habitat ofA. baumannii, although the pathogen 
has been isolated from other sources, including foods, anthropods, animals, and humans 
(Baumann et al., 1968; Berlau et al., 1999; Mussi et al., 2005; Fournier et al., 2006; Munoz-Price 
et al., 2008). Moreover, protozoans such as Acanthamoeba have been reported to support the 
growth of A. baumannii, and act as itsreservoir in water (Cateau et al., 2011). Recently, alarming 
reports indicating the potential presence of A. baumannii in water systems have been reported 
from several parts of the world (Ferreira et al., 2011; Zhang et al., 2013). The ability of A. 
baumannii to thrive in water may result in fatal infections in all age groups (Kempf et al., 2012).  
          Chlorine has long been used as a disinfectant in drinking water and in swimming pools to 
inactivatepathogenic microorganisms, thereby making the water safe for human use (Ngwenya et 
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al, 2013; Shrivastava et al., 2004; WHO, 1993). In the United States, the Environmental 
Protection Agency (EPA) recommends a maximum free chlorine level of 4 ppm in drinking 
water (EPA, 2012). In addition to the standards described for chlorine in drinking water, the 
Centers for Disease Control and Prevention (CDC) have recommended 1-3 ppm chlorine in 
swimming pool water for recreational purposes (CDC, 2012). However, a variety of 
microorganisms have been recovered from drinking water distribution systems that maintained 
chlorine levels between 0.5 – 1.0 ppm, indicating that the low levels of chlorine may not 
inactivate harmful microorganisms (Means et al., 1981; Ridgway et al., 1982; LeChevallier et al., 
1984). It is also reported that chlorine used in potable water can selectively promote the survival 
of antibiotic resistant bacteria (Armstrong et al., 1981; 1982; Murray et al., 1984; Shrivastava et 
al., 2004). For instance, drinking water with suboptimal levels of chlorine selectively promoted 
the survivalof multidrug resistant Pseudomonas aeruginosa (Shrivastava et al., 2004). 
          Since A. baumannii could potentially contaminate drinking or recreational water, and that 
chlorine at the recommended levels may not be effective in killing the pathogen, the current 
research investigated the viability of A. baumannii in water containing chlorine at the 
recommended levels for potable and recreational usage. In addition, the effect of chlorine 
exposure on various antibiotic resistance genes in the pathogen was investigated. 
                                         2.    MATERIALS AND METHODS 
2.1. A. baumannii Strains and Growth Conditions 
          Eight strains of A. baumannii, including 251847, 134882, 173795, 474030, 190451, 
163731, and 251352 kindly gifted by the International Health Management Associates (IHMA, 
City, State), and ATCC 17978 (fatal meningitis isolate) were used in the chlorine survival study. 
The antibiotic resistance profile of the seven clinical strains was Amikacin (MIC 64 μg/mL), 
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Amoxicillin (MIC 32 μg/mL), Cefepime (MIC 32 μg/mL), Ceftazidime (MIC 32 μg/mL), 
Ceftriaxone (MIC 64 μg/mL), Imipenem (MIC 4–32 μg/mL), Levofloxacin (MIC 8 μg/mL), 
Meropenem (MIC 16 μg/mL), Minocycline (MIC 1–16 μg/mL), and Piperacillin (MIC 128 
μg/mL). 
          Each strain of A. baumannii was grown individually on MDR Acinetobacter and Leeds 
Acinetobacter agars (Hardy Diagnostics, Santa Maria, CA), and an individual colony from these 
media was subcultured at least 3 times in tryptic soy broth (TSB; Difco) for 24 h at 37oC with 
shaking (200 rpm). After the subcultures, the bacterial cells were harvested from an overnight 
culture by centrifugation at 3600 x g for 30 min at 4oC. The cells were washed twice in sterile 
phosphate buffered saline (PBS, pH=7.2), and the bacterial cell pellet was finally resuspended in 
PBS to get a final concentration of 109 cfu/ml. The bacterial population in the inoculum was 
confirmed by broth dilution and surface plating on tryptic soy agar (TSA; Difco) plates. 
2.2. A. baumannii Survival Assay 
          The effect of chlorine on A. baumannii viability in water was determined using a published 
protocol (Zhao et al., 2001). Deionized, non-chlorinated (EMD Millipore, Billerica, MA) water 
was used for the study. For each experiment, different chlorine concentrations (0.2, 1, 2, 3 and 4 
ppm) in water were achieved by adding standard chlorine solution (Aqua solutions, Deer Park, 
Texas) to pre-sterilized deionized water. The final concentration of free chlorine in water was 
confirmed using a digital titrator (Pocket colorimeterTMII, Hach, City, State). One ml of A. 
baumannii suspension containing 109 cfu/ml was added to 99 ml of the sterile deionized water 
containing chlorine at the specifiedconcentrations in a 200 ml Erlenmeyer flask. After thorough 
mixing, 0.5 ml samplesweretaken at 30, 60, 90 and 120 s, and transferred to 4.5 ml neutralizing 
broth for buffering chlorine (NB, Difco). Serial ten-fold dilutions in PBS were made and 0.1 ml 
 73 
of each dilution was surface plated on duplicate on TSA. The plates were incubated at 37oC for 
24 h. After enumeration of the colonies, the counts were expressed as log10 cfu/ml. The colonies 
on TSA were confirmed as A. baumannii by streaking on MDR and Leeds agar plates. Each 
experiment was done in duplicates and the experiment replicated three times. 
2.3. Antibiotic Resistance Gene Expression 
2.3.1. RNA Isolation and cDNA Synthesis 
          Three selected strains of A. baumannii (ATCC 17978, 251847 and 474030) were grown on 
MDR plates and subcultured in TSB separately at 37oC as before. The bacterial populations in 
the cultures were confirmed to contain ~8 log10 CFU/ml by plating appropriate dilutions on TSA. 
The overnight culture from the tubes was centrifuged, washed twice, and reconstituted in PBS as 
described before. One ml each of this reconstituted culture was transferred to two sets of tubes 
containing 9 ml of sterile deionized water. To one set of tubes, chlorine was added to yield a 
concentration of 2 ppm in water. The other set of tubes served as non-chlorine control. The 2 
ppm concentration was chosen for the RT-qPCR analysis since the United States Department of 
Health (USDH) recommends the free chlorine concentration of 1 and 3 ppm to disinfect 
swimming pools (CDC, 2012). Both set of tubes were incubated at 25oC for 15 min. The 
bacterial culture from each tube was centrifuged at 12,000 x g for 2 min at 4oC. The supernatant 
was discarded and the pellet was added with 0.5 ml of sterile water and 1 ml of RNA protect 
reagent (Qiagen, Valencia, CA). The mixture was then incubated at 25oCfor 5 min. The RNeasy 
mini kit (Qiagen) was used for extracting total RNA from the control and chlorine-treated 
samples. The RNA was quantified using Nanodrop (Biorad) by measuring the absorbance at 260 
and 280 nm. Super-script II reverse transcriptase kit (Invitrogen, Carlsbad, CA) was used for 
cDNA synthesis from the extracted RNA. 
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2.3.2. Real-Time quantitative PCR (RT-qPCR) 
          The following A. baumannii genes were used for the gene expression analysis: efflux 
pump genes adeA, adeB, adeC, and abeM; chloramphenicol resistance gene, cmr, β-lactam 
resistance gene, blaP; sulphonamide resistance gene sul1; tetracycline resistance gene, tetA, and 
multidrug resistance protein, mdrp.  
            The primers specific for the genes and for the endogenous control (16SrRNA) were 
designed using the Primer Express software® (Applied Biosystems, Foster City, CA, USA based 
on Acinetobacter baumannii AB0057 genome (CP001182.1) published in the NCBI database 
(Adams et al., 2008). The primers used in the study are provided in Table 1. Custom synthesized 
primers for each gene were obtained from Integrated DNA Technologies (Foster City, CA USA). 
RT-qPCR was done with the ABI Prism 7900 sequence detection system (Applied Biosystems) 
using the SYBR green assay under custom thermal cycling conditions with the normalized 
mRNA as template (Kollanoor-Johny et al., 2012). The samples were analyzed in duplicates and 
standardized against 16S rRNA gene expression. The relative changes in mRNA expression 
levels were determined using comparative threshold cycle (CT) method (2-CT) between the 
chlorine-exposed and chlorine non-exposed A. baumannii. 
2.4. Statistical Analysis 
          The counts of A. baumannii in the control and treated samples were logarithmically 
transformed (log10 cfu/ml) to aid in statistical analysis. Since there was no significant difference 
in bacterial counts between the strains following exposure to chlorine treatment, the data from 
the eight strains were pooled and averaged.  Data analysis was done using the PROC-MIXED 
procedure of statistical analysis software (SAS version 9.2; SAS Institute Inc., Cary, NC, USA). 
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Fisher’s least significance test (LSD) was used to determine the differences between the means at 
a P level of  0.05.  
3. RESULTS AND DISCUSSION 
              In order to determine if A. baumannii survived the recommended levels of chlorine, we 
determined the survival of the pathogen exposed to 0 to 4 ppm of free chlorine for 30, 60, 90 and 
120 seconds in deionized water (Table 2). All the eight A. baumannii controls, where no chlorine 
was added had 107 CFU/ml bacteria at all the time points tested. When exposed to free chlorine 
levels ranging from 0.2 to 4 ppm, all the eight strains of A. baumannii survived with no 
significant decrease in their counts throughout the sampling period (P> 0.05).  
              Chlorine is generally used to disinfect both potable and recreational water with 
stipulated standards for inclusion as determined by the EPA, FDA and CDC. However, previous 
studies have indicated that chlorine was not completely effective in inactivating several 
pathogenic bacteria. For example, Yersinia enterocolitica, Yersinia pestis, Pasteurella multocida 
and Hafnia alvei were isolated from chlorine treated sewage water, indicating the inefficiency of 
chlorine in killing these pathogens (Murray et al., 1984). In another study, Zhao et al. (2001) 
reported an isolate of E.coli O157:H7 showing tolerance of up to 2-ppm free chlorine treatment 
after one minute exposure, among six other isolates tested in their study. In yet another study, E. 
coli isolated from a chlorine treated swimming pool were found to be resistant to chlorine for up 
to 9 passages (Farkas-Himsley, 1964). High tolerance of bacteria to disinfectants could either be 
intrinsic or resulting from mutation. Additionally, wide spread use of disinfectants has been 
reported to trigger the selection of resistant strains (McDonnell et al., 1999). 
              Since we observed that A. baumannii could survive all the tested concentrations of 
chlorine in water, we investigated the effect of chlorine exposure on major antibiotic resistance 
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determinants using RT-qPCR.The effect of chlorine exposure on the expression of ten major 
antibiotic resistance genes conferring resistance to multiple antibiotics in A. baumannii was 
studied in ATCC strain 17978, 251847, and 474030. The ATCC strain was selected since it has 
been widely studied, and was isolated from a 4-month-old infant who died of fatal meningitis 
resulting from an acute infection. The results on the effect of chlorine exposure on antibiotic 
resistance genes in theATCC strain are shown in Figure 1. Among the various genes tested, those 
controlling antibiotic efflux pumps in A. baumannii, namely adeA, adeB, and abeM were 
significantly up-regulated by more than six folds when compared to the control, while the efflux 
pump gene, adeC and the gene encoding chloramphenicol resistance,cmr were up-regulated by 
about four folds (P< 0.05). A three fold up-regulation was noticed in blaP that confers resistance 
to β lactam group of antibiotics upon exposure to chlorine (P> 0.05). Exposure to chlorine also 
resulted in an increase in the expression of aminoglycoside (ami) and sulphonamide (sul1) 
resistance genes by three and four folds, respectively (P<0.05). In addition, an eight-fold up-
regulation (P< 0.05) of the gene encoding multiple drug resistance protein (mdrp) in A. 
baumannii was observed following exposure to chlorine. However, no significant change in the 
expression of tetracyclineresistance encoding gene, tetA was observed upon exposure to chlorine 
(P> 0.05). The results revealed that the efflux pump genes were more up-regulated compared to 
the antibiotic resistance genes (Figure 1), highlighting the involvement of efflux pump 
mechanisms on rapid exposure to chlorine (Xi et al., 2009). Figure 2 shows the antibiotic gene 
expression in A. baumannii 251847, where a significant up-regulation was observed in the 
expression of adeC, cmr and tetA by nine, four and five folds, respectively (P< 0.05). However, 
the expression of all the other genes tested was decreased following chlorine exposure (P< 0.05). 
In A. baumannii 470430, a significant up-expression of all genes except tetA (Figure 3) was 
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observed after exposure to chlorine (P< 0.05), which was similar to trend observed in the ATCC 
isolate. To summarize, despite variations in the expression levels of specific genes, exposure to 
chlorine induced the expression of multiple antibiotic resistance genes in all the three isolates of 
A. baumannii studied. 
             Although preventative chlorine levels are in use, several reports suggest that chlorine at 
suboptimal levels could induce the expression of critical genes in pathogenic bacteria. Shi and 
coworkers reported that chlorine enhanced the expression of antibiotic resistance genes in 
diverse microbial populations isolated from drinking water (Shi et al., 2013). Similarly, an 
increase in the expression of several antibiotic resistance genes was noted in E.coli and P. 
aeruginosa by other research groups (Shrivastava et al., 2004; Krige, 2009). It was observed that 
exposure to chlorine induced stress tolerance in bacteria making them more resistant to 
antibiotics (Armstrong et al., 1981; 1982). It is also reported that chlorine exposure could induce 
over expression of efflux pumps resulting in the pumping out of disinfectants and antibiotics by 
bacteria (Xi et al., 2009).  
          In conclusion, the current investigation indicated that free chlorine concentration of up to 4 
ppm was not effective in killing multidrug resistant A. baumannii isolates. All A. baumannii 
isolates were able to survive the recommended levels of chlorine in water. Further, chlorine 
exposure was found to increase the expression of efflux pumps and genes conferring resistance 
to chloramphenicol, sulphonamides, and beta-lactam group of antibiotics. Further studies are 
required to understand the mechanism behind chlorine-induced gene expression in A. baumannii, 
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Table 1:  List of primers used in determing the effect of chlorine on antibiotic resistance genes in 
A. baumannii 
Gene Sequence (5’ 3’) 
16S-rRNA (F) TCGCTAGTAATCGCGGCATCACGCTGGCGGC 
                   (R) GACGGGCGGTGTGTACAAG 
adeA  (F) TGACCGACCAATGCACCTT 
 
          (R) GCAACAGTTCGAGCGCCTAT 
 
adeB  (F) CCGATGACGTATCGAAGTTAGGA 
 
          (R) CCGATGACGTATCGAAGTTAGGA 
 
adeC  (F) ACGGCCCCAGAAGTCTAGTTC 
 
          (R) CGATTAACCCCAATAACCCAGTT 
 
adeM (F) GGTACATGGAAGCCCAGTTCTT 
 
          (R) CCACTTTCTCTTGCCATTGCT 
 
blaP   (F) ACACTAGGAGAAGCCATGAAGCTT 
 
          (R) GCATGAGATCAAGACCGATACG 
 
cmr  (F) CTATTTGAATTTGCGGTTTATATTGG 
 
          (R) TGCACTTACACCGAAATCTTCAG  
 
























Table 2. Effect of chlorine concentrations on the survival of A. baumannii in deionized water* 
Chlorine(ppm) Isolates A. baumannii (log10 CFU/ml) 
  30 sec 60 sec 90 sec 120 sec 
0 ATCC  7.38±0.07 7.42±0.06 7.41±0.06 7.44±0.06 
 
251847 7.29±0.03 7.33±0.1 7.28±0.04 7.35±0.05 
134882 7.58±0.07 7.56±0.06 7.58±0.05 7.54±0.07 
173795 7.34±0.09 7.38±0.09 7.35±0.1 7.33±0.08 
474030 7.32±0.09 7.37±0.12 7.37±0.11 7.39±0.1 
190451 7.52±0.06 7.63±0.07 7.64±0.05 7.47±0.1 
163731 7.48±0.07 7.48±0.04 7.49±0.09 7.48±0.08 
251352 6.8±0.14 6.86±0.18 6.8±0.15 6.81±0.14 
0.2 ATCC 
17978 
7.42±0.13 7.44±0.09 7.45±0.1 7.47±0.11 
 
251847 7.33±0.07 7.27±0.08 7.28±0.07 7.32±0.09 
348 2 7.53±0.06 7.54±0.05 7.46±0.05 7.57±0.07 
173795 7.21±0.07 7.15±0.03 7.09±0.02 7.1±0.02 
474030 7.31±0.09 7.33±0.1 7.33±0.1 7.25±0.12 
190451 7.58±0.09 7.65±0.1 7.62±0.12 7.57±0.1 
163731 7.45±0.1 7.55±0.09 7.52±0.07 7.64±0.09 
251352 7.15±0.03 7.19±0.05 7.17±0.04 7.23±0.09 
1 ATCC 
17978 
7.34±0.1 7.39±0.09 7.33±0.05 7.46±0.09 
 
251847 7.27±0.07 7.24±0.09 7.2±0.06 7.16±0.07 
348 2 7.3±0.06 7.33±0.05 7.25±0.05 7.38±0.05 
173795 7.22±0.15 7.09±0.01 7.1±0.02 7.09±0.04 
474030 7.31±0.07 7.37±0.11 7.33±0.11 7.29±0.12 
190451 7.71±0.03 7.66±0.04 7.68±0.02 7.74±0.03 
163731 7.53±0.06 7.48±0.06 7.58±0.09 7.49±0.14 
251352 7.13±0.03 7.14±0.04 7.16±0.02 7.12±0.04 
2 ATCC 
17978 
7.45±0.05 7.42±0.05 7.42±0.05 7.37±0.04 
 
251847 7.14±0.02 7.17±0.05 7.2±0.07 7.19±0.07 
348 2 7.44±0.08 7.41±0.09 7.38±0.09 7.36±0.11 
173795 7.62±0.08 7.64±0.08 7.63±0.08 7.57±0.07 
474030 7.39±0.16 7.43±0.12 7.36±0.15 7.2±0.1 
190451 7.64±0.08 7.66±0.05 7.55±0.06 7.55±0.07 
163731 7.43±0.13 7.43±0.1 7.4±0.09 7.47±0.13 
251352 6.06±0.08 6.03±0.05 6.05±0.08 5.89±0.19 






Isolates A. baumannii (log10 CFU/ml) 
  30 sec 60 sec 90 sec 120 sec 
3 ATCC 
17978 
7.47±0.05 7.44±0.06 7.31±0.05 7.31±0.1 
 251847 7.16±0.05 7.21±0.06 7.17±0.06 7.19±0.06 
 348 2 7.45±0.1 7.41±0.09 7.38±0.04 7.36±0.08 
 173795 7.59±0.07 7.61±0.08 7.61±0.09 7.57±0.08 
 474030 7.31±0.15 7.48±0.17 7.47±0.16 7.32±0.13 
 190451 7.58±0.07 7.56±0.06 7.5±0.1 7.56±0.07 
 163731 7.53±0.06 7.46±0.03 7.44±0.06 7.57±0.07 
 251352 6.15±0.04 6.16±0.05 6.16±0.07 6.07±0.05 
4 ATCC 
17978 
7.37±0.1 7.31±0.09 7.23±0.09 7.21±0.11 
 251847 7.19±0.07 7.17±0.1 7.34±0.16 7.3±0.15 
 348 2 7.38±0.12 7.62±0.11 7.3±0.07 7.29±0.06 
 173795 7.65±0.09 7.61±0.09 7.62±0.09 7.63±0.1 
 474030 7.39±0.15 7.34±0.16 7.25±0.11 7.36±0.16 
 190451 7.53±0.04 7.54±0.04 7.55±0.05 7.52±0.05 
 163731 7.51±0.05 7.61±0.04 7.53±0.06 7.56±0.09 
 251352 6.19±0.16 6.14±0.14 6.14±0.16 6.08±0.15 














Fig 1: Effect of chlorine exposure on A. baumanniiATCC 17978 antibiotic resistance gene 
expression  
 
* Genes significantly different from the control atP< 0.05  
Fig 2: Effect of chlorine exposure on A. baumannii 251847 antibiotic resistance gene expression
 




Fig 3: Effect of chlorine exposure on A. baumannii 474030 antibiotic resistance gene expression  
 








































         Multi-drug resistant (MDR) Acinetobacter baumannii is a major nosocomial pathogen 
causing a wide spectrum of clinical conditions with significant mortality rates.Identification of A. 
baumannii by traditional cultural methods requires at least 48 to 72 h for obtaining results. In 
addition, biochemical methods for the confirmation of A. baumannii from other Acinetobacter 
species are not completely accurate. Thus, there is a need for rapid methods for specific 
identification of A. baumannii. 
 Polymerase chain reaction is a powerful molecular technique, which has been widely used 
for detecting microorganisms. The objective of this study was to develop a real-time polymerase 
chain reaction (RT-PCR) for specifically detecting A. baumannii in water and blood using TaqMan 
primer/probe set targeting a highly conserved 102-bp DNA sequence in adeT, an efflux pump 
found in A. baumannii. For testing the limit of detection, RT-PCR was done directly with 10-fold 
dilutions of A. baumannii suspension in blood or water (106 CFU to 101 CFU) and various 
concentrations of genomic DNA. Further, the sensitivity of the RT-PCR was tested after 
enrichment of A. baumanniiin tryptic soy broth. The results revealed that all the A. 
baumanniiisolates yielded a 102-bp PCR product, however, none of the tested negative control 
isolates, including other Acinetobacter species produced any amplification. The sensitivity of 
PCR for detecting A. baumannii in blood and water was 3 log10 CFU/ml or 0.1 ng/ml of DNA. 
However, upon enrichment, the PCR was able to detect 2 log10 and 1 log10 CFU/ml of A. 
baumanni in water after 6 h and 14 h of incubation at 37oC, respectively. The RT-PCR 
developed in this study enabled specific detection of A. baumannii, and may be useful in the 




Acinetobacter baumannii is a Gram-negative, aerobic, coccobacillus belonging to the 
family Moraxellaceae in the order Gammaproteobacteria (Peleg et al., 2008; Perez et al., 2007). 
Acinetobacter species are ubiquitously present in soil and water, which are considered to be their 
natural habitats (Baumann,et al., 1968). A. baumannii has also been detected in water systems 
from multiple parts of the world (Ferreira et al., 2011; Zhang et al., 2013). In addition, A. 
baumannii can persist in biofilms on a variety of abiotic surfaces for prolonged periods of time in 
the hospital environment, thereby serving as a continuous source of infection. A. baumannii is 
the most common bacterium associated with infections linked to intensive care units 
(Giamarellou, 2010, Lambert et al., 2011), and it can cause a variety of nosocomial infections in 
humans, including meningitis, pneumonia, urinary tract infections and bacteremia, with a high 
mortality rate (Seifert et al., 1995; Dijkshoorn et al., 2007; Perez et al., 2007; Wisplinghoff et al., 
2004; Peleg et al., 2008; Pereira et al., 2013). During the last decade, A. baumannii has emerged 
as an important human pathogen due to increasing reports of infections associated with the 
organism and rapid emergence of multidrug-resistant (MDR), extensively-drug resistant (XDR), 
and pandrug-resistant (PDR) strains (Peleg et al, 2008; Durante-Mangoni and Zarrilli, 2011). The 
Infectious Diseases Society of America has ranked A. baumannii as one of the highest priority, 
antibiotic-resistant pathogens to control due to its rapid propensity to develop drug resistance, 
and the availability of a restricted choice of antibiotics to treat infections caused by the bacterium 
(Talbot et al., 2006).   
          Bacteriological detection of A. baumannii by traditional cultural methods requires atleast 48 
to 72 h for obtaining accurate results (Levi et al., 2003; Jamal et al., 2014). Furthermore, the four 
Acinetobacter species, namely A. calcoaceticus (formerly Acinetobacter genomospecies 1), A. 
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baumannii (formerly Acinetobacter genomospecies 2), Acinetobacter pitti (formerly 
Acinetobacter genomospecies 3) and Acinetobacter nosocomalis (formerly Acinetobacter 
genomospecies 13TU) are phenotypically and genotypically closely related, and are difficult to 
be distinguish from each other. Therefore, they are grouped together and referred to as A. 
baumannii -A. calcoaceticus complex (ABC) (Gerner-Smidt et al., 1991; Gerner-Smidt, 1992). 
Although several Acinetobacter species show hemolysis on sheep blood agar at 37oC, this 
property, which is sometimes used for species identification is not exhibited by the members of 
ABC complex (Peleg, 2008). In Gram staining procedure, Acinetobacter spp. is sometimes 
difficult to de-stain, and depending on its stage of growth, can exhibit either Gram negative or 
Gram positive characteristics (Howard et al., 2012). Moreover, species identification using 
biochemical tests cannot differentiate A. calcoaceticus from A. baumannii, and specific detection 
needs to be complemented by further tests, which could be time consuming in clinical diagnosis. 
Thus, there is a need for accurate assays for specific detection of A.baumannii in clinical and 
environmental samples.  
          Polymerase chain reaction (PCR) is a widely used method for rapid, specific and sensitive 
detection of microorganisms (Garibyan and Avashia, 2013; Law et al., 2015).Real-time Taqman 
PCR assays are faster and more sensitive than conventional PCR, and allow the quantification of 
target DNA (Livak et al., 1995). The objective of this study was to develop and optimize a real 
time-PCR for specific detection of A. baumannii from water and blood by targeting adeT, a RND 
(resistance-nodulation-division) type efflux pump gene in A. baumannii not reported to be 




2. MATERIALS AND METHODS 
2.1. Bacterial Strains and Growth Conditions 
          The various bacterial strains used in the study are listed in Table 1. A total of seventeen 
clinical and environmental isolates of A. baumannii were used to study the specificity of the 
PCR. The negative control isolates included important water- and blood-borne pathogens as well 
as other Acinetobacter species from the ABC complex- A. calcoaceticus, A. nosocomalis and A. 
pitti. Each strain of A. baumannii was individually grown on MDR Acinetobacter and Leeds 
Acinetobacter agar plates (Hardy Diagnostics, Santa Maria, CA, USA), and a single colony from 
these media was sub-cultured at least three times in tryptic soy broth (TSB; Difco, Becton 
Dickinson, Sparks, MD, USA) for 24 h at 37oC. The bacteria used as negative controls were 
cultured in TSB (Difco). 
2.2. Preparation of Genomic DNA  
          The genomic DNA from Gram-negative and Gram-positive bacteria was extracted,as 
previously described by Mohan Nair and Venkitanarayanan (2006). For testing the sensitivity of 
PCR, A. baumannii DNA was extracted from one milliliter aliquots of sterile deionized water or 
defibrinated sheep blood (Quad Five, Ryegate, MT, USA) containing 106, 105, 104, 103, 102, or 
101 CFU using InstaGene Matrix (Bio-Rad, Hercules, CA, USA) or BiOstic bacteremia DNA 
isolation kit (Mo Bio, Carlsbad, CA), respectively.  Concurrently, the sensitivity of PCR was 
also tested with serial dilutions of DNA ranging from 100 ng to 0.1 ng/l.  
2.3. Detection of A. baumannii in water and blood on pre-enrichment 
          In order to increase the sensitivity of the PCR, an enrichment of the sample was done in 
TSB (Mohan Nair and Venkitanarayanan, 2006; Afendy and Son, 2015), where one milliliter 
aliquots of water or blood containing 103, 102 or 101A. baumannii were separately transferred to 
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9 ml of TSB, and incubated at 37oC for 6 or 14 h. Following incubation, A. baumannii genomic 
DNA was extracted and subjected to real-time PCR analysis. 
2.4. Primers for A. baumannii specific PCR 
Using Basic Local Alignment Search Tool (BLAST), a primer pair targeting A. baumannii RND 
efflux pump gene adeT was designed. The forward primer (5’-CGGAATATCCGCTTTCATTT-
3’) and reverse primer (5’-GACAAATTAAAAGCTGGTTT-3’) target a highly conserved 102 
bp region of the gene. The probe sequence was (5’ CGCGGTAACTGACCAGCCACC–3’) with 
FAM- labeled on the 5’ end and TAMRA on the 3’ end. All oligonucleotides were synthesized, 
labeled and purified by Integrated DNA Technologies (Coralville, IA, USA).  
2.5. Real-Time TaqMan PCR Assay 
Real-time TaqMan PCR assay was performed using StepOnePlus™ Real-time PCR detection 
system (Applied Biosystems, Foster city, CA, USA). Thirty l reactions containing 15 l 2x 
Taqman universal PCR master mix (Applied Biosystems), PCR primers at a concentration of 300 
nM and the probe at 100 nM, and 6 lof DNA were prepared. The PCR parameters were 50oC 
for 2 min, 95oC for 10 min and then 40 cycles at 95oC for 15s and 60oC for 1 min. The software 
in the instrument calculates and plots the changes in the fluorescence signalfrom the probe ( 
Rn) versus the cycle number during the PCR reaction. Rn is calculated using the formula  Rn 
= (Rn+) – (Rn-), where Rn+ is the fluorescence signal of the PCR product at a given time and 
Rn- is the fluorescence signal of the baseline emission during the initial amplification cycles, 
where no signal was detected. To determine the efficiency of the PCR, a standard curve was 
plotted using the Ct number (cycle number at which the  Rn crosses the threshold) and log 
CFU/ml of A. baumannii. The primer-probe set was subsequently tested using standard curve 
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dilutions of the A. baumannii or A. baumannii DNA. Regression analyses of the data wasdone to 
determine the correlation coefficient. 
4. RESULTS AND DISCUSSION 
 
Clinically, the rapid detection of A. baumannii is important for reducing the time before 
patients receive appropriate treatment, which is especially critical in light of its multi-drug 
resistance, and ability to cause a wide spectrum of infections with high mortality rates. 
Moreover, accurate detection of A. baumannii in water is crucial as its ability to survive in water 
may result in fatal infections in all age groups (Kempf et al., 2012). Therefore, this study was 
undertaken to develop a real-time PCR for rapid and specific detection of A. baumannii in blood 
and water. A literature search revealed that a few PCRs have been developed for the specific 
detection of A. baumannii or multiplex detection for Acinetobacter spp. For example, McConnell 
and group (2012) reported a real-time PCR based on the conserved sequence of ompA for 
detecting A. baumannii. Although these researchers reported a high sensitivity for the PCR, they 
failed to include A. calcoaceticus, A. nosocomalis and A. pitti from the ABC complex as negative 
controls in the assay. Similarly, Higgins et al. (2007) developed a conventional PCR based on 
gyrB for differentiating between A. baumannii and A. nosocomalis; however, they did not screen 
the PCR with highly related A. calcoaceticus and A. pitti from the ABC complex. Recently, Chen 
and coworkers reported a multiplex PCR based on 16S-23S ribosomal RNA intergenic region, 
gyrB, and recA genes for the identification of A. baumannii, A. nosocomialis and A. pitti. 
Although a large number of isolates were screened in the PCR, the authors did report 16 false 
positives and 10 false negatives in their results (Chen et al., 2014). 
The PCR developed in this study is based on a highly conserved 102-bp DNA sequence 
of adeT, a RND type efflux pump gene reportedly present only in A. baumannii. The specificity 
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of this DNA sequence was confirmed by BLAST analysis with all published prokaryotic gene 
sequences, including related Acinetobacter sequences available in the NCBI GenBank database. 
The specificity of the primers was further tested using In silico PCR (Bikandi et al., 2004), a 
computational tool to detect the efficacy of primer-probe set to amplify the target DNA 
sequence. The primer pair was used to amplify the target genomic DNA sequence from 17 
strains of A. baumannii and 28 strains of other important bacteria,including members from the 
ABC complex, and important water-borne bacteria such as Escherichia coli, Salmonella, Vibrio 
cholera, Shigella and Pseudomonas, and other major pathogens such as Klebsiella pneumoniae, 
Listeria monocytogenes and Yersinia pseudotuberculosis.All the isolates of A. baumannii 
showed the amplification of a 102-bp DNA sequence within the targeted 40 cycles, whereas 
none of the negative isolates, including the other members of the ABC complex yielded any 
amplification (Fig. 1 and 2), thereby indicating that the PCR developed was able to specifically 
detect A. baumannii.  
          The sensitivity of PCR was tested with DNA extracted from serial dilutions of A. 
baumannii counts (ranging from 1 log10 to 6 log10 CFU/ml) present in water and blood. After 40 
cycles of amplification, the PCR could detect as low as 3 log10 CFU/ml of A. baumannii in both 
water (Fig 3A) and blood (Fig 4A). A standard curve showing the relation between the threshold 
cycle and A. baumannii counts was plotted for detection in water (Fig 3B), where each point 
represents A. baumannii count corresponding to the CT value. The regression analysis performed 
with bacterial count as the independent variable and CT value as the dependent variable revealed 
a correlation coefficient (R2) of 0.94. Similarly, the relationship between threshold cycle and A. 
baumannii counts in blood was found to have a correlation coefficient of 0.99 (Fig 4B). The PCR 
sensitivity was also tested with serial dilutions of A. baumannii DNA, where the lowest limit of 
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detection was found to be 0.1ng/l of DNA (Fig 5A), with a correlation coefficient of 0.98 (Fig 
5B).  
          Since the lowest detection limit of the PCR was 3 log10CFU/ml of A. baumannii both in 
water and blood, a pre-PCR enrichment of the samples was done to improve the sensitivity of 
PCR detection. The results revealed that enrichment for 6 h at 37oC improved the sensitivity of 
detection to 2 log10 CFU/ml (Fig. 6A), whereas the PCR could detect as low as 1 log10 CFU/ml 
of A. baumannii in water after 14 h of enrichment (Fig. 6B). However, the enrichment step failed 
to improve the sensitivity of detection in blood samples, which remained at 3 log10 CFU/ml even 
after enrichment (data not shown).  This could be attributed to the presence of potential PCR 
inhibitors such as heme (Akane et al., 1994), and hemoglobin and lactoferrin (Al-Soud et al., 
2001) present in blood. 
 In summary, the PCR reported in the manuscript was able to detect A. baumannii 
specifically, without any false positives, especially from other species in the ABC complex. The 
PCR could potentially be used for rapid detection of the pathogen from environmental and 
clinical samples; however, further optimization for improving its sensitivity of detection in 
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Table 1: List of bacterial strains used in detecting specificity of PCR 
 
No. Species Strain 
1 A. baumannii 189632a 
2 A. baumannii 260177 a 
3 A. baumannii 474030 a 
4 A. baumannii 190451 a 
5 A. baumannii 251847 a 
6 A. baumannii 251382 a 
7 A. baumannii 249958 a 
8 A. baumannii 252128 a 
9 A. baumannii 313099 a 
10 A. baumannii 195652 a 
11 A. baumannii 173795 a 
12 A. baumannii 163731 a 
13 A. baumannii 320452 a 
14 A. baumannii 134882 a 
15 A. baumannii Naval 17b 
16 A. baumannii OIFC 109 b 
17 A. baumannii ATCC 17978 
18 Acinetobactercalcoaceticus ATCC BAA-346 
19 Acinetobacter genomospecies 3 ATCC 17922 
20 Acinetobacter genomospecies 13 TU ATCC 17903 
21 Burkholderia cepacia ATCC 25608 
22 Serratia marcescens 361c 
23 Escherichia coliK88 842d 
24 Yersinia pseudotuberculosis 399 c 
25 Edwardsiella tarda 296 c 
26 Proteus mirabilis 366 c 
27 Proteus vulgaris 365 c 
28 Aeromonas hydrophilia 191 c 
29 Shigella flexneri 387 c 
30 Edwardsiella ictaluri 92/132 d 
31 Erwinia carotovora 351c 
32 Bacillus cereus F3802A/84 d 
33 Klebsiella pneumoniae 344 c 
34 Pseudomonas fragi 110 c 
35 Salmonella Enteritidis SE 90 d 
36 Salmonella enterica serovar typhi 372c 
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37 Listeria monocytogenes Scott Ae 
38 Staphylococcus aureus ATCC 35556 
39 Enterobacter aerogenes NRRL B-115f 
40 Providencia alcalifaciens 368 c 
41 Citrobacter fruendii 239 c 
42 Chromobacterium violaceum 294 c 
43 Pseudomonas fluorescence 105 c 
45 Vibrio parahaemolyticus ATCC 17802 
46 Vibrio cholerae ATCC 51394 
 
a International Health Management Associates (IHMA), Schaumburg, IL, USA 
b Bei resources, Manassas, VA 
c Presque Isle cultures, Presque Isle, PA 
d Culture collection, Food Microbiology Laboratory, University of Connecticut, Storrs, CT 
e M.P. Doyle, Center for Food Safety, University of Georgia, Griffin, GA 
f A. P. Rooney, Microbial Genomics and Bioprocessing Research Unit, Agricultural research Service Culture 















Fig 1:  Specificity of the primer-probe set in differentiating A. baumannii from other members of 
ABC complex  
 
 
Fig 2: Specificity of the primer-probe set in differentiating A. baumannii from other important 




Fig 3: (A) Sensitivity of the primer-probe set in detecting A. baumannii in water 
(B) Standard curve generated from the amplification plot (Fig 3A).R2 was calculated from plots 











Fig 4: (A) Sensitivity of the primer-probe set in detecting A. baumannii in blood 
(B) Standard curve generated from the amplification plot (Fig 4A). R2 was calculated from plots 








Fig 5: (A) Sensitivity of the primer-probe set in detecting A. baumannii DNA 
(B) Standard curve generated from the amplification plot (Fig 5A). R2 was calculated from plots 













Fig 6: Sensitivity of the primer-probe set in detecting A. baumannii in water after enrichment 
















































Multidrug resistant (MDR) Acinetobacter baumannii is a major nosocomial pathogen causing a 
wide range of clinical conditions with significant mortality rates. A.baumannii strains are 
equipped with a multitude of antibiotic resistance mechanisms, rendering them resistant to most 
of the currently available antibiotics. Thus, there is a critical need to explore novel strategies for 
controlling antibiotic resistance in A.baumannii. This study investigated the efficacy of two food-
grade, plant-derived antimicrobials (PDAs), namely trans-cinnamaldehyde(TC) and eugenol 
(EG) in decreasing A.baumannii’s resistance to seven β-lactam antibiotics, including ampicillin, 
methicillin, meropenem, penicillin, aztreonam, amoxicillin and piperacillin. Two MDR 
A.baumannii isolates (ATCC 17978 and AB251847) were separately cultured in tryptic soy broth 
(~6logCFU/ml) containing the m inimum inhibitory concentration (MIC) of TC or EG with or 
without the MIC of each antibiotic at 37oC for 18 h. A.baumannii strains not exposed to the 
PDAs or antibiotics served as controls. Following incubation, A.baumannii counts were 
determined by broth dilution assay. In addition, the effect of PDAs on the permeability of outer 
membrane and efflux pumps in A. baumannii was measured. Further, the effect of TC and EG on 
the expression of A.baumannii genes encoding resistance to β-lactam antibiotics (blaP), efflux 
pumps (adeABC) and multi-drug resistant protein (mdrp) was studied using real-time 
quantitative  PCR (RT-qPCR). The experiment was replicated three times with duplicate samples 
of each treatment and control. The results from broth dilution assay indicated that both TC and 
EG in combination with antibiotics increased the sensitivity of A.baumannii to all the tested 
antibiotics (P<0.05). The two PDAs inhibited the function of A. baumannii efflux pump, 
(AdeABC), but did not increase the permeability of its outer membrane. Moreover, RT-qPCR 
data revealed that TC and EG down-regulated the expression of majority of the genes associated 
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with β-lactam antibiotic resistance, especially blaPand adeABC (P<0.05).The results suggest that 
TC and EG could potentially be used along with β-lactam antibiotics for controlling MDR 





Acinetobacter baumannii is a multi-drug resistant (MDR) Gram-negative, aerobic 
bacillus that has emerged as a major cause of nosocomial infections with mortality rates ranging 
from 34 to 61% (Wiexaorek et al., 2008; Karageorgopoulos and Falagas, 2008; Esterly et al., 
2011). In humans, MDR A. baumannii causes a wide-spectrum of clinical conditions, including 
pneumonia (Leung et al., 2006), blood-stream infections (Wisplingoff et al., 2004; CDC, 2014), 
meningitis (Metan et al., 2007), urinary tract infections (Sunenshine et al., 2007), and wound 
infections (Scott et al., 2007). In addition, reports of other manifestations such as endocarditis, 
peritonitis, and osteomyelitis associated with A. baumannii have been reported (Olut and Erkek, 
2005; Menon et al., 2006; Wieczorek et al., 2008). A. baumannii is ranked as one of the most 
common bacteria associated with intensive care units (Garnacho-Montero and Amaya-Villar, 
2010; Ulu-Kilic et al., 2013), and is difficult to treat due to its resistance to most of the currently 
available antibiotics (Maragakis and Perl., 2008; Doi et al., 2009; Neonakis et al., 2011; Al 
Mobarak et al., 2014; Ellis et al., 2015). For example, carbapenems, which were once the 
antimicrobials of choice for treating A. baumannii, are no longer completely effective due to 
resistance development by the bacterium (Falagas et al., 2006; Bassetti et al., 2008; Abbott et 
al., 2013; Fonseca et al., 2013). Similarly, although polymyxins have been successfully used to 
treat A. baumannii infections, strains resistant to these drugs have appeared (Hernan et al., 2009; 
Lean et al., 2014; Pogue et al., 2015). In light of these reports, the Infectious Diseases Society of 
America ranked A. baumannii as one of the top priority, antibiotic-resistant pathogens to target 
due to its rapid propensity to develop drug resistance, and a limited choice of antibiotics 
available to treat infections caused by this bacterium (Talbot et al., 2006; Shales et al., 2013).    
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A. baumannii is considered to be multidrug resistant, if it exhibits resistance to more than 
three classes of antibiotics (Falagas et al., 2006). The resistance of A. baumannii to antibiotics 
has been attributed to multiple mechanisms, including reduced permeability of its outer 
membrane to antibiotics, constitutive expression of drug efflux pumps, and its ability to acquire 
and incorporate genetic elements such as plasmids, transposons, and integrons (Giamarellou et 
al., 2008; Cai et al., 2012). In addition, A. baumannii has a significantability to produce biofilms 
on various surfaces (Espinal et al., 2012; Longo et al., 2014), which not only increases the 
potential of A. baumannii for nosocomial spread, but also contributes to its resistance to 
antibiotics and virulence (Lee et al., 2008; Rao et al., 2008). Thus, there is a critical need to 
explore novel strategies for treating A. baumannii infections. 
Traditionally, plants have served as a source of novel drugs for treating a variety of 
diseases in humans (Cowan, 1999; FAO, 2013). A variety of plant-derived compounds 
possessing antimicrobial properties against a wide range of microorganisms have been 
documented (Kon and Rai, 2012; Upadhyay et al., 2014).  Wang et al. (2010) reported the 
antimicrobial effects of four components of ginger against MDR strains of the bacterium. 
Similarly, the essential oil from coriander was found to exert either synergistic or additive effects 
with antibiotics such as tetracycline, chloroamphenicol, ciprofloxacin, gentamicin, piperacillin 
and cefoperazone against A. baumannii (Duarte et al., 2012).Recently, Saghi et al. (2015) 
showed that the essential oil from Origanum vulgare possessed potent antimicrobial activity 
against MDR A. baumannii. In addition, previous research from our laboratory indicated that 
several plant-derived antimicrobials (PDAs), including trans-cinnamaldehyde, an ingredient in 
cinnamon, eugenol (present in clove) and carvacrol and thymol obtained from oregano oil and oil 
of thyme, respectively decreased antibiotic resistance in MDR S. Typhimurium DT 104 
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(Kollanoor-Johny et al., 2010). These investigators observed that trans-cinnamaldehyde reduced 
DT 104’s resistance to 5 antibiotics, where thymol and carvacrol decreased resistance to 3 
antibiotics.  
The β-lactam group of antibiotics are the most commonly prescribed antibiotics for the 
treatment of bacterial infections worldwide (Pitout et al., 1997; Thakuria and Lahon, 2013). A. 
baumannii is capable of producing β-lactamases that can hydrolyze the β-lactam ring of 
penicillins, cephalosporins, and carbapenems, thereby conferring resistance to these antibiotics. 
Therefore, this study investigated the efficacy of trans-cinnamaldehyde(TC) and eugenol (EG) in 
increasing the sensitivity of A. baumannii to seven β-lactam antibiotics. In addition, the effect of 
these PDAs on genes conferring resistance to β-lactam antibiotics in A. baumannii was 
determined.  
2. MATERIALS AND METHODS 
2.1. A. baumannii Cultures and Growth Conditions 
          Two clinical isolates of A. baumannii, namely 251847 (International Health Management 
Associates, IL), and 17978 (ATCC; fatal meningitis isolate) were used in the study.All 
bacteriological media used in the study, except Leeds MDR Acinetobacter agar, were purchased 
from Difco (Becton Dickinson, Sparks, MD, USA). Leeds MDR agar was procured from Hardy 
Diagnostics (Santa Maria, CA, USA). The bacterial isolates were cultured separately overnight 
in 10 ml tryptic soy broth (TSB), followed by streaking on Leeds MDR Acinetobacter agar plates 
and incubation at 37oC for 24 h. An individual colonyfrom Leeds MDR Acinetobacter agar was 
sub-cultured twice in 10 ml of TSB at 37oC for 24 h with agitation to reach ~ 8 log10 CFU/ml. 
The cultures were sedimented by centrifugation (3700 x g, 15 min, 4oC) and the pellet was 
washed twice and re-suspended in sterile phosphate buffered saline (PBS; pH 7.2). The cultures 
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were then diluted appropriately in PBS to obtain 5 to 6 log10 CFU/ml to be used as the inoculum. 
The bacterial populationin the inoculum was confirmed by plating on tryptic soy agar (TSA) 
with incubation at 37oC for 24 h. 
2.2. Plant-Derived Antimicrobials (PDAs) and chemicals 
Trans-cinnamaldehyde (≥98%; TC, trans-3-Phenyl-2-propenal), Eugenol (≥98%; EG,4-Allyl-2-
methoxyphenol), 1- N-phenylnaphthylamine (NPN), EDTA, ethidium bromide (EtBr), carbonyl 
cyanide m-chlorophenylhydroazone (CCCP) and pyronin Y were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). 
2.3. Determination of sub-inhibitory concentration (SIC) and minimum inhibitory 
concentration (MIC) of PDAs against A. baumannii 
The SIC and MIC of TC and EG against A. baumannii were determined as previously reported 
(Johny et al., 2010; Amalaradjou and Venkitanarayanan, 2011). Tryptic soy broth (10 ml) tubes 
containing 1 to 10 lof TC or EG (Sigma-Aldrich) in increments of 0.5 lwere inoculated 
separately with A. baumannii at ~ 6 log10CFU/ml, and incubated at 37
oC for 24 h. Tubes without 
any added PDAs served as controls. After incubation, the samples were serially diluted (1:10) in 
PBS, plated on TSA, and incubated at 37oC for 24 h before counting the colonies. The highest 
concentration of TC or EG that did not inhibit A. baumannii growth after 24 h of incubation was 
selected as the SIC, while the lowest concentration of the antimicrobial that inhibited visible 
growth of the bacteria after 24 h incubation was taken as the MIC of that treatment. The 
experiment was done in duplicates and repeated three times. 
2.4. Effect of PDAs on antibiotic resistance in A. baumannii 
The β-lactam antibiotics tested in the current study included Ampicillin, Meropenem, 
Methicillin, Penicillin, Aztreonam, Amoxicillin and Piperacillin (Sigma-Aldrich). Previously 
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published MIC of each aforementioned antibiotic against A. baumanniiwas used in the study 
(Table 2) (Vashist et al., 2011; Morfin-Otero and Dowzicky et al., 2012; Malone and Kwon, 
2013).  
          To determine the effect of combination of PDAs and antibiotics on A. baumannii, the MIC 
of each antibiotic and that of TC/EG were added to 10 ml TSB containing A. baumannii(~ 6 
log10 CFU/ml), and incubated at 37
oC for 24 h (Kollanoor-Johny et al., 2010). The bacterial 
counts were determined after broth dilution assay and surface plating of appropriate dilutions on 
TSA. The treatments included only A. baumannii (positive control), A. baumannii + antibiotic, A. 
baumannii+ PDA and A. baumannii+ antibiotic + PDA. In addition, suitable controls, including 
A. baumannii + diluent (ethanol) and A. baumannii + ethanol + antibiotic were also included. 
Duplicate samples were included for each treatment, and the experiment was replicated three 
times. 
2.5. Efflux pump inhibition assay 
          To study the effect of TC and EG on inhibiting the action of efflux pumps in A. 
baumannii, ethidium bromide (EtBr) and pyronin Y efflux assays were performed according to a 
published protocol (Chusri et al., 2009). Overnight cultures of A. baumannii were washed twice 
and resuspended in PBS containing 0.4 % glucose to an OD600 of ~ 0.5. The bacterial suspension 
was added with the MIC of TC/EG or CCP (positive control, 100 M), and incubated at 37oC for 
5 h. A. baumannii suspension in PBS + 0.4 % glucose served as control. After incubation, 200 l 
of the treatments/control was separately transferred to a 96-well microtiter plate, followed by 
addition of EtBr (Sigma) to a final concentration of 4 mg/l, and the fluorescence was measured at 
excitation 530 nm and emission 645 nm. The assay was repeated with pyronin Y (Sigma) at a 
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final concentration of 5 mg/l at 530 nm and emission 645 nm. The experiment was repeated three 
times with duplicates for A. baumannii 17978 and A. baumannii 251847. 
2.6. Outer membrane permeabilization assay 
          To study the effect of TC and EG on the outer membrane of A. baumannii, NPN uptake 
assay was performed using a published protocol (Chusri et al., 2009). Overnight A. baumannii 
17978 and A. baumannii 251847 cultures were separately washed and resuspended in 5 mM 
HEPES buffer to an OD600 ~ 0.5. Aliquots of 100 l of A. baumannii suspension were transferred 
to a microtiter plate along with the MIC of TC/EG or EDTA 1 mM/HEPES buffer. This was 
followed by addition of 40 M of NPN to make the total volume to 200 l, the fluorescence was 
measured within 3 min at excitation 355 nm and emission 460 nm, and continuously recorded for 
3 h every 10 min. The experiment was repeated three times with duplicates in each treatment. 
2.7. Effect of PDAs on antibiotic resistance gene expression in A. baumannii 
2.7.1. RNA extraction and cDNA synthesis 
To study the effect of TC and EG on genes associated with resistance to β-lactam 
antibiotics in A. baumannii, bacterial cultures were grown separately with or without the SIC of 
TC/EG at 37oC in TSB to mid-log phase. A. baumannii grown witheither antibiotic alone or PDA 
alone were also included as controls. After incubation, the cultures were subjected to 
centrifugation (12000 x g, 15 min, 4oC) and the resultant pellet was added with 0.5 ml of 
RNAase free, sterile water and 1 ml of RNA protect reagent (Qiagen, Valencia, CA, USA). The 
total RNA from each sample was extracted using the RNeasy mini kit (Qiagen), and the 
manufacturer’s instructions were followed in estimating the total RNAusing Nanodrop 
(ThermoFisher Scientific, Waltham, MA, USA). Super-script II reverse transcriptase kit 
(Invitrogen, Carlsbad, CA, USA) was used for cDNA synthesis, and the resultant cDNA was 
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used as a template for RT-qPCR. The amplified product was detected using SYBR Green 
reagents. 
2.7.2.Real-Time Quantitative PCR (RT-qPCR) 
The antibiotic resistance genes of A. baumanniiassayedfor expression analysis included 
efflux pump genes, namely adeA, adeB, adeC; β-lactam resistance gene,blaP; and the multidrug 
resistance protein gene, mdrp. Primer Express software® (Applied Biosystems, Foster city, CA, 
USA) was used for designing the primers specific for the genes and for the endogenous control 
(16S rRNA). The primers were designed fromA. baumannii AB0057 genome (CP001182.1) 
published in the NCBI database (Adams et al., 2008), and their sequences are provided in Table 
1. The custom synthesized primers were obtained from Integrated DNA Technologies (Foster 
City, CA, USA). RT-qPCR was performed with StepOnePlusTM Real Time PCR system 
(Applied Biosystems) using the SYBR green assay (Applied Biosystems) under custom thermal 
cycling conditions with the normalized RNA as the template (Bookout and Mangelsdorf, 2003). 
Duplicate samples were analyzed and standardized against 16S rRNA gene expression. The 
relative changes in mRNA expression levels were determined using comparative threshold cycle 
(CT) method (2-CT) between the control and the treatments. 
2.8. Statistical analysis 
A completely randomized design with a factorial treatment structure was used. The 
factors included two A. baumannii strains, seven antibiotics, and two PDAs. The data were 
analyzed using the PROC GENMOD procedure of Statistical Analysis Software (SAS ver. 9.4; 
SAS Institute Inc., Cary, NC). Least square means were considered significant at P< 0.05. The 
data comparisons for gene expression study were made using Students t-test. The difference was 
considered significant at P<0.05. 
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3. RESULTS 
          The SICs of TC and EG against A. baumannii were found to be 1.1 mM (0.015 %) and 1.8 
mM (0.03 %), respectively, while the MIC was 4 mM (0.05% TC and 0.065 % EG) for both 
PDAs. Although a previously reported MIC of each antibiotic against A. baumannii was used in 
the study, both A. baumannii isolates grew approximately by 2.0 log10CFU/ml after 24 h 
(antibiotic control), as observed in Fig 1-4.  In the presence of the MIC of TC, the bacterial count 
after 24 h did not change significantly from the inoculation of level of 6.0 log10CFU/ml (Fig. 1 
and 2) as expected. However, when A. baumannii was grown in the presence of each antibiotic 
and TC, its growth after 24 h was significantly decreased in comparison to that in the positive 
control, antibiotic control and TC control (P < 0.05). In both A. baumannii isolates, the greatest 
sensitivity was observed to methicillin and lowest sensitivity was seen against ampicillin and 
meropenem (Fig. 1 and 2). Similarly, the sensitivity of both A. baumannii isolates to all seven 
antibiotics was significantly increased in the presence of EG, as indicated by the reduced growth 
after 24 h (P < 0.05) (Fig. 3 and 4). In A. baumannii 17978, the greatest sensitivity was observed 
against ampicillin (Fig. 3), whereas A. baumannii 251847 was maximally sensitive to amoxicillin 
(Fig. 4).   
   The results of the efflux pump inhibition assay using EtBr and pyronin Y in A. 
baumannii ATCC 17978 and A. baumannii 251847 are presented in Fig. 5-8. The MIC of TC 
and EG resulted in an increased accumulation of EtBr inside bacterial cells, as indicated by an 
increase in fluorescence compared to the PBS control (P<0.05) (Fig. 5-6).CCCP, an efflux pump 
inhibitor used as a positive control (Magnet et al., 2001) also resulted in an increase in 
fluorescene indicatingsupression of efflux pump in A. baumannii. However, a similar increase in 
the fluorescence was not observed for pyronin Y compared to the PBS control (Fig. 7 and 8). 
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The results of NPN uptake assay in A. baumannii ATCC 17978 and A. baumannii 251847 are 
presented in Fig. 9 and Fig. 10, respectively. Neither TC nor EG increased NPN uptake, while 
the EDTA control did show an increase in fluorescence. Further, the samples treated with TC or 
EG demonstrated a decrease in fluorescence over time (data not shown). 
The effect of seven antibiotics and two PDAs and their combination on the expression of 
various antibiotic resistance genes in A. baumannii17978 is depicted in Fig. 11A-G. It was 
observed that compared to control, the expression of all tested genes was up-regulated (P < 0.05) 
following A. baumannii growth in the presence of the antibiotics. However, TC significantly 
down-regulated the expression of major genes conferring resistance to β-lactam antibiotics 
compared to control (P< 0.05). The genes encoding efflux pump adeA and adeB were down 
regulated by ~ 6- and 9-fold, respectively. Moreover, the expression of genes encoding β-
lactamase (blaP) and the multiple drug resistance protein (mdrp) was decreased by ~3-folds(P< 
0.05)Similar to the results observed with TC, all antibiotic resistance genes were down-regulated 
on exposure to EG compared to control (P< 0.05). The expression of genes encoding efflux 
pumps, adeA and adeB were down-expressed by 3- and 14- fold, respectively. Similarly, blaP 
and mdrp were also down-regulated in both strains (P< 0.05). The combination of TC or EG with 
the antibiotics also resulted in a down-regulation of majority of the tested genes (P< 0.05). 
Among the combinations of TC or EG with the seven antibiotics, the combination 
containingaztreonam resulted in a significant down-regulation of all the tested genes compared to 
control (Fig. 11D). The combination of EG with piperacillin (Fig. 11C) or penicillin (Fig. 11F) 





          Rapid emergence of antibiotic resistance in pathogenic microorganisms, especially to 
multiple antibiotics has ignited research efforts to discover novel antibiotics and develop 
effective derivatives of currently available antibiotics. However, few promising antibiotics are 
under development, and the rapidity and complexity of resistance development in pathogens 
have further exacerbated the situation. In light of this, a potential viable approach was explored 
to reduce bacterial antibiotic resistance in the development of inhibitors of resistance 
mechanisms in bacteria (Renau et al., 1999; Walsh and Fanning, 2008). This strategy involves 
the co-administration of an antibiotic with an “inhibitor”, which counteracts bacterial resistance 
mechanism(s), thereby rendering the resistant pathogen sensitive to the drug. The advantage of 
this approach is that it makes it possible to continue the use of current antibiotics, for which in-
depth pharmacological and toxicological data are already available. In this regard, PDAs 
represent a potential natural group of “inhibitors” of bacterial antibiotic resistance mechanisms. 
Abundant literature exists on the antimicrobial properties of a variety of plant compounds 
against a wide range of microorganisms (Upadhyay et al., 2014; Burt 2004), however, only a 
handful of studies have addressed their effect on bacterial antibiotic resistance, especially in 
Gram negative bacteria (Galluci et al., 2006; Chursi et al., 2009; Kollanoor-Johny et al., 2010; 
Ilic et al., 2014). In the current study, both TC and EG enhanced the sensitivity of A. baumannii 
to all seven β-lactam antibiotics tested (Fig. 1-4). This is evident from the significant reductions 
in bacterial counts observed in the samples containing PDA and antibiotics as compared to that 
in the treatments containing each PDA or antibiotic alone. 
A. baumannii has been reported to exhibit resistance to β-lactam antibiotics through 
several mechanisms, including the production of β-lactamases, changes in penicillin-binding 
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proteins (PBPs), altering the structure and number of porin proteins, decreased membrane 
permeability, and by use of efflux pumps that exit antibiotics out of the bacterial cell (Vila et al., 
2007; Manchanda et al., 2010; Bonin et al., 2013; Tang et al., 2014). Moreover, the presence of 
efflux pumps and MDR proteins in A. baumannii contribute significantly to both intrinsic and 
acquired resistance to antibiotics (Lomovskaya and Bostian, 2006). The A. baumannii genome 
encodes a wide array of multidrug efflux systems, including AdeABC, a resistance-nodulation-
division (RND) family-type pump (Damier-Piolle et al., 2008;Wieczorek et al., 2008; Sun et al., 
2014; Yoon et al., 2013). The substrates for this pump include beta-lactams, aminoglycosides, 
erythromycin, chloramphenicol, tetracycline, fluoroquinolone, trimethoprim, and ethidium 
bromide (Magnet et al., 2001., Higgins et al., 2004; Heritier et al., 2005; Peleg et al., 2007). The 
three component structures of AdeABC include the inner membrane fusion protein (AdeA), 
transmembrane component (AdeB) and an outer membrane protein (AdeC), with the inactivation 
of adeB resulting in the loss of pump function and multidrug resistance (Magnet et al., 2001).  
In order to determine if TC or EG exerted an inhibitory effect on the aforementioned 
efflux pumps in A. baumannii, an efflux pump inhibition assay was performed with EtBr and 
pyronin Y along withCCCP, a documented efflux pump inhibitor(Magnet et al., 2001; Chusri et 
al., 2009). Ethidium bromide and Pyronin Y are known substrates for AdeABC and AdeIJK 
efflux pumps, respectively (Magnet et al., 2001; Chusri et al., 2009; Damier-Piolle et al., 2008; 
Xing et al., 2014). Both TC and EG resulted in the inhibition of AdeABC efflux pump in the two 
tested A. baumannii strains, as evident from the increase in fluorescence in the treated samples 
compared to PBS control (Fig. 5 and 6). However, the PDAs did not exert any inhibitory effect 
on the action of AdeIJK efflux pump in A. baumannii, as evident from the lack of difference in 
fluorescence units between PDA-treated and PBS control samples (Fig. 7 and 8). Similarly, the 
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results from the NPN uptake assay revealed that TC and EG did not increase A. baumannii’s 
outer membrane permeability, as seen from Fig. 9 and 10, where no increase in fluorescence was 
observed in PDA-treated A. baumannii as against the samples treated with EDTA, a known outer 
membrane permeabilizer in Gram-negative bacteria (Alakomi et al., 2006; Helander and 
Sandholm, 2008). These results indicate that TC and EG increased the sensitivity of A. 
baumannii to the tested antibiotics at least in part by inhibiting the efflux pump, AdeABC. 
For ascertaining if TC or EG exerted an inhibitory effect on any of the antibiotic 
resistance genes conferring resistance to β-lactam antibiotics in A. baumannii, we performed a 
RT-qPCR on mRNA extracted from A. baumannii following growth in the presence and absence 
of the PDAs. The results from the RT-qPCR revealed that TC and EG in combination with or 
without each antibiotic significantly down-regulated the expression of the majority of genes that 
confer resistance to β-lactam antibiotics (Fig. 11A-G). Among the various genes screened, those 
encoding efflux pumps, adeA and adeB were maximally down-regulated by both PDAs.  These 
results concur with the results from the EtBr efflux pump inhibition assay, and suggest that TC 
and EG enhanced the efficacy of the seven β-lactam antibiotics against A. baumannii by 
thwarting the various resistance mechanisms, especially those involving the efflux pumps.  
In conclusion, the results of this study suggest the potential use of TC and EG in 
conjunction with the currently available β-lactam antibiotics for the treatment for MDR A. 
baumannii infections. However, efficacy studies in suitable animal models are warranted before 
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Table 1: List of primers used in detecting A. baumannii antibiotic resistance genes 
 
Gene Sequence (5’3’) Function 
 




adeA  (F) TGACCGACCAATGCACCTT 
 
Efflux pump 
































Multiple drug resistance 
protein 








         (R) GACGGGCGGTGTGTACAAG  
Note: (F), forward; (R), reverse. 
 
Table 2: MIC of antibiotics used in testing against A. baumannii 




















Fig 1. Effect of TC in combination with β-lactam antibiotics in A. baumannii 17978 
Bars with different superscripts differ from each other within a cluster (P < 0.05). A. baumannii 
17978 was grown with each β-lactam antibiotic either alone or in combination with TC. Bacteria 
not exposed to any treatments (PC) and bacteria exposed to only TC (TC Ctrl) served as controls 














Fig 2. Effect of TC in combination with β-lactam antibiotics in A. baumannii 251847 
Bars with different superscripts differ from each other within a cluster (P < 0.05). A. baumannii 
251847 was grown with each β-lactam antibiotic either alone or in combination with TC. 
Bacteria not exposed to any treatments (PC) and bacteria exposed to only TC (TC Ctrl) served as 













Fig 3. Effect of EG in combination with β-lactam antibiotics in A. baumannii 17978 
Bars with different superscripts differ from each other within a cluster (P < 0.05). A. baumannii 
17978 was grown with each β-lactam antibiotic either alone or in combination with EG. Bacteria 
not exposed to any treatments (PC) and bacteria exposed to only EG (EG Ctrl) served as controls 














Fig 4. Effect of EG in combination with β-lactam antibiotics in A. baumannii 251847 
Bars with different superscripts differ from each other within a cluster (P < 0.05). A. baumannii 
251847 was grown with each β-lactam antibiotic either alone or in combination with EG. 
Bacteria not exposed to any treatments (PC) and bacteria exposed to only EG (EG Ctrl) served as 













Fig 5. Intracellular accumulation of ethidium bromide (EtBr) in A. baumannii ATCC 17978 after 
treatment with MIC of TC and EG, as measured by fluorescence intensity  
A. baumannii ATCC 17978 was added with MIC of TC/EG or CCCP (100 M) and incubated 
for 5 h at 37oC. Fluorescence (excitation 530 nm and emission 645 nm) was measured after 





































Fig 6. Intracellular accumulation of ethidium bromide (EtBr) in A. baumannii 251847 after 
treatment with MIC of TC and EG, as measured by fluorescence intensity.  
A. baumannii 251847 was added with MIC of TC/EG or CCCP (100 M) and incubated for 5 h 
at 37oC. Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition of 

































Fig 7. Intracellular accumulation of pyronin Y in A. baumannii ATCC 17978 after treatment with 
MIC of TC and EG, as measured by fluorescence intensity. 
A. baumannii ATCC 17978 was added with MIC of TC/EG and incubated for 5 h at 37oC. 
Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition of pyronin 












Fig 8. Intracellular accumulation of pyronin Y in A. baumannii 251847 after treatment with MIC 
of TC and EG, as measured by fluorescence intensity.  
A. baumannii 251847 was added with MIC of TC/EG and incubated for 5 h at 37oC. 
Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition of pyronin 












Fig 9. Effect of TC and EG on A. baumannii 17978 outer membrane, as measured by 
fluorescence intensity. HEPES buffer (5.0 mM) was used as a control.  
A. baumannii ATCC 17978 was added with MIC of TC/EG or EDTA (1 mM) and incubated for 
5 h at 37oC. Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition 












Fig 10. Effect of TC and EG on A. baumannii 251847 outer membrane, as measured by 
fluorescence intensity. HEPES buffer (5.0 mM) was used as a control.  
A. baumannii 251847 was added with MIC of TC/EG or EDTA (1 mM) and incubated for 5 h at 
37oC. Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition of 














Fig 11. Effect of TC and EG on antibiotic resistance genes in A. baumannii 17978. 
(A) A. baumannii 17978 was grown withthe SIC of TC/EG either alone or in combination with 
amoxicillin, and RT-qPCR was done to test the effect of the treatments on major antibiotic genes 
in A. baumannii. Bacteria exposed to amoxicilllin alone and bacteria not exposed to any 















































(B) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with 
ampicillin and RT-qPCR was done to test the effect of the treatments on major antibiotic genes 
in A. baumannii. Bacteria exposed to ampicillin alone and bacteria not exposed to any treatments 



















































(C) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with 
piperacillin and RT-qPCR was done to test the effect of the treatments on major antibiotic genes 
in A. baumannii. Bacteria exposed to piperacillin alone and bacteria not exposed to any 



























































(D) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with 
aztreonam and RT-qPCR was done to test the effect of the treatments on major antibiotic genes 
in A. baumannii. Bacteria exposed to aztreonam alone and bacteria not exposed to any treatments 
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(E) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with 
meropenem and RT-qPCR was done to test the effect of the treatments on major antibiotic genes 
in A. baumannii. Bacteria exposed to meropenem alone and bacteria not exposed to any 






























































(F) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with 
penicillin and RT-qPCR was done to test the effect of the treatments on major antibiotic genes in 
A. baumannii. Bacteria exposed to penicillin alone and bacteria not exposed to any treatments 



















































(G) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with 
methicillin and RT-qPCR was done to test the effect of the treatments on major antibiotic genes 
in A. baumannii. Bacteria exposed to methicillin alone and bacteria not exposed to any 

































































Efficacy of trans-cinnamaldehyde and eugenol in reducing A. baumannii adhesion to and 


























Acinetobacter baumannii is a multi-drug resistant, nosocomial pathogen causing a variety of 
disease conditions in humans. After A. baumannii outbreaks in military combat personnel in Iraq 
and Afghanistan, reports of A. baumannii wound infections are increasingly recognized. In 
addition, A. baumannii’s ability to form biofilms and colonize epithelial cells potentially 
increases the invasiveness of this pathogen. Thus, in light of the multidrug resistance and biofilm 
producing capacity, new strategies for controlling A. baumannii wound infections are necessary. 
This study investigated the efficacy of two natural, plant-derived antimicrobials (PDAs), namely 
trans-cinnamaldehyde (TC) and eugenol (EG) for decreasing A. baumannii adhesion to and 
invasion of normal human keratinocytes (HEK001). The efficacy of two PDAs for inhibiting A. 
baumannii biofilm formation was determined using an in vitro collagen matrix wound model. In 
addition, the effect of TC and EG on A. baumannii biofilm architecture was visualized using 
confocal scanning microscopy. Further the effect of both PDAs on A. baumannii genes critical 
for biofilm synthesis was determined using real-time quantitative PCR (RT-qPCR). Both TC and 
EG significantly reduced A. baumannii adhesion to HEK001 by ~2 to 2.5 log10 CFU/ml (P < 
0.05), and invasion by ~2 to 3 log CFU/ml, compared to the controls (P < 0.05). Further, after 24 
and 48 h, TC inhibited biofilm formation by ~1.5 and ~2 to 3.5 log10 CFU/ml, while EG 
decreased biofilm-associated bacteria by ~2 and ~3.5 log10 CFU/ml, respectively, compared to 
controls (P < 0.05). Confocal microscopy revealed that TC and EG resulted in the death of 
biofilm-associated A. baumannii, and disrupted the biofilm architecture. RT-qPCR results 
indicated that the two phytochemicals significantly down-regulated the transcription of genes 
associated with A. baumannii biofilm production. The results suggest that both TC and EG could 
 148 
potentially treat A. baumannii wound infections; however, their efficacy in in vivo models needs 




1.  INTRODUCTION 
 
          Acinetobacter baumannii has emerged into a significant human pathogen, especially 
linked to infections acquired from hospital settings, with high case fatality rates 
(Karageorgopoulos and Falagas, 2008; Wieczaorek et al., 2008; Esterly et al., 2011). In addition, 
A. baumannii has the ability to form biofilms on a variety of biotic and abiotic surfaces (Gaddy 
et al., 2009). The ability of A. baumanniito persist in the nosocomial environment is the most 
important factor aiding in the transmission of infection in nursing homes and nosocomial settings 
(Simor et al., 2002; Denton et al., 2005; Rastogi et al., 2007). During the last few years, A. 
baumannii has become resistant to the majority of currently available antibiotics, and the 
emergence of multidrug-resistant (MDR), extensively-drug resistant (XDR), and pandrug-
resistant (PDR) strains have been documented (Peleg et al, 2008; Durante-Mangoni and Zarrilli, 
2011). This has generated concern among health-care professionals due to the limited choice of 
drugs available for controlling A. baumannii infections, especially in light of its ability to cause a 
wide range of infections, including pneumonia, bacteremia, meningitis and urinary tract 
infections (Bergogne-Bérézin and Towner, 1996; Peleg et al., 2008). In addition to these 
conditions, MDR A. baumannii has been increasingly linked to skin and soft-tissue infections 
(Ali et al., 2014). Further, A. baumannii is an important pathogen causing persistent wound 
infections in burn victims, leading to loss of skin grafts and delayed wound healing (Bergogne-
Berezin, 1995; Santucci et al., 2003; Sharma, 2007). During the last decade, the US military 
health care system has recorded a significant increase in the incidence of MDR A. baumannii in 
combat-related wound infections (Scott et al., 2007; Murray, et al., 2008). 
               Traditionally, the management of wound infections consists of using gauze and cotton 
wool to protect the wound from outside contamination (Jones et al., 2006), coupled with creams 
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or powders incorporated with topical bioactive agents that either act as antimicrobial drugs or 
aacelerate the wound healing process (Katti et al., 2004; Dai et al., 2010). Antibiotics such as 
minocycline, vancomycin, neomycin and streptomycin incorporated in novel delivery systems 
such as chitosan, polyox and carrageenan have been found effective in the treatment of wounds 
(Aoyagi et al., 2007; Labovitiadi et al., 2012; Boateng et al., 2013; Pawar and Rhee., 2014). 
However, the multi drug resistance of A. baumannii combined with the inefficacy of systemic 
antibiotics in reducing pathogen loads in granulation wounds has necessitated alternate strategies 
for treating and controlling wound infections caused by the pathogen (Selcuk et al., 2012; 
Thompson et al, 2014).  
Several plant-derived compounds have been investigated for their potential would healing 
properties. Aloe vera was reported to inhibit bacterial growth and enhance wound healing by 
stimulating macrophage activity (Djeraba and Quere, 2000; Ni, 2004). Plant compounds such as 
curcumin haveaccelerated healing of irradiated wounds in mice (Jagetia and Rajanikant, 2012). 
The treated mice had an increased collagen deposition, fibroblast and vascular densities 
compared to untreated mice. Similarly, essential oils from citrus, thyme, and cinnamon have 
exhibited wound-healing properties in vivo and/or in vitro (Dursun et al., 2003; Woollard et al., 
2007; Ranasinghe et al., 2013). Liakos et al. (2014) reported the efficacy of essential oils such as 
cinnamon, elicriso italic, chamomile blue or lemon incorporated at 66% (dry weight percentage) 
in sodium alginate films against E. coli and C. albicans, and proposed their application as 
disposable wound dressings. Chitosan films incorporated with thyme oil were also effectively 
applied as antibacterial and permeable films for wound healing (Altoik et al., 2010). Farahpour 
and Habibi (2012) reported that extracts of cinnamon improved the healing of excised wounds in 
rats by increasing epithelialization. Similarly, Kamath et al. (2003) observed that oral 
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supplementation of ethanolic extracts of cinnamon bark increased the rate of wound contraction 
and granulation tissue weight in Wistar rats. Additional studies revealed that phytochemicals 
such as trans-cinnamaldehyde and eugenol did not produce any detrimental effect on 
keratinocyte cell growth and proliferation (Daker et al., 2013; Kalmes and Blomeke et al., 2012).  
The objective of this study was to investigate the efficacy of trans-cinnamaldehyde and 
eugenol in reducing the adhesion and invasion of A. baumannii in human keratinocytes, and to 
inhibit A. baumanniibiofilm formation in an in vitro wound model.  
2. MATERIALS AND METHODS 
2.1. Bacterial strains and growth conditions 
          Three clinical isolates of A. baumannii isolated from wound infections (Navel-17, OIFC-
109 and WC-487) (BEI resources, Manassas, VA, USA) were used in the study.  Each strain was 
cultured separately in 10 ml of Tryptic soy broth (TSB, Difco, Becton Dickinson, Sparks, MD, 
USA) at 37oC for 24 h to reach an optical density at 600 nm of ≥ 0.7, yielding ~ 8 logCFU/ml. 
The cultures were sedimented by centrifugation (3,600 X g, 15 min at 4oC), the pellet was 
washed twice, re-suspended in sterile PBS, and used as the inoculum. The A. baumannii 
population in the inoculum was determined by serial dilution and plating on Tryptic soy agar 
(TSA, Difco) with incubation at 37oC for 24 h. 
2.2. Plant-Derived Antimicrobials (PDAs) 
Trans-cinnamaldehyde (≥98%; trans-3-Phenyl-2-propenal, TC) and eugenol (≥98%; 4-Allyl-2-
methoxyphenol, EG) were purchased from Sigma-Aldrich (St. Louis, MO, USA).  
2.3. Determination of Sub-inhibitory concentrations (SIC) and Minimum inhibitory 
concentration (MIC) of PDAs 
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The SIC and MIC of TC and EG against A. baumannii were determined as previously reported 
(Amalaradjou and Venkitanarayanan, 2011; Kollanoor-Johny et al., 2010). Tryptic soy broth (10 
ml) tubes containing 1 to 10 l of TC or EG (Sigma-Aldrich) in increments of 0.5 lwere 
inoculated separately with A. baumannii at ~6 log10CFU/ml, and incubated at 37
oC for 24 h. 
Tubes without any added PDAs served as controls. After incubation, the samples were serially 
diluted (1:10) in PBS, plated onTSA, and incubated at 37oC for 24 h before counting the 
colonies. The highest concentration of TC or EG that did not inhibit A. baumannii growth after 
24 h of incubation was selected as the SIC, whereasthe lowest concentration of eachantimicrobial 
that inhibited bacteria growth after 24 h incubation was selected as the MIC of that treatment. 
The experiment was done in duplicates and repeated three times. 
2.4. Keratinocyte cell culture 
          Human skin keratinocyte, HEK001 (ATCC CRL-2404) was obtained from the American 
Type Culture Collection (Manassas). HEK001 cells were grown in a 25 cm2 cell culture flask 
containingkeratinocyte serum free medium (K-SFM) supplemented with human recombinant 
epidermal growth factor (Invitrogen, Carlsbad, CA, USA) at 37oC for 24-48 hin an aerobic 
incubator containing 5% CO2.  
2.5. Adhesion and invasion assay 
         The effect of MIC of TC and EG on A. baumannii adhesion to and invasion of HEK001 
keratinocyte cellswas determined, aspreviously described (Muthaiyan et al., 2012). Twenty four-
well tissue culture plates (BD, Franklin Lakes, NJ, USA) were seeded with ~105 cells/well, and 
incubated at 37oC for 24 h in 5% CO2 incubatorto form a monolayer. A. baumannii was grown to 
mid-log phase at 37oC, washed and re-suspended in K-SFM with MIC of TC or EG. Bacteria 
suspended in K-SFM alone or with ethanol (diluent) were used as controls. Aliquots of 100 μl of 
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the bacterial suspension containing approximately 6 log10CFU/well (MOI 1:10) was inoculated 
in duplicates into the HEK001 monolayer, and incubated at 37oC in 5% CO2 incubator for 2 h. 
For the adhesion assay, the infected monolayers after incubation was washed three times with 
PBS, and the cells were lysed using 0.1 % Triton X-100 (Invitrogen). The number of viable 
adhered bacteria was enumerated by serial dilution and culturing on TSA plates. For the invasion 
assay, the HEK001 monolayer was washed three times with PBS, followed by incubation for 2 h 
in K-SFM containing gentamicin (100 μg/ml) (Invitrogen) in order to kill the extracellular 
bacteria. Subsequently, the wells were washed three times with PBS and the cells were lysed 
using 0.1 % Triton X-100 to release the intracellular bacteria. The number of invaded bacteria 
was enumerated by serial dilution in PBS and culturing on TSA plates. Both adhesion and 
invasion assays were done in duplicates and the experiment was repeated three times.  
2.6. Quantification of biofilm in invitro  
          In order to replicate the conditions of a chronic wound, an in vitro system that 
accommodates bacterial aggregates in a simulated wound fluid and collagen matrix model, as 
described by Werthen et al., (2010) was used. Briefly 24-well cell culture plates were coated 
with collagen solution (rat tail collagen type 1, BD Biosciences, San Jose, CA). A 10 ml collagen 
solution (2 mg/ml) contained 1 ml of 0.1% acetic acid, 2 ml collagen stock solution (10 mg/ml) 
and 6 ml cold simulated wound fluid (SWF, 50% fetal calf serum and 50% physiological NaCl in 
0.1% peptone) and 1 ml of 0.1 M NaOH. One ml of the above solution was added to each 24-
well plate, which wasincubated at 37oC for 1 h. After complete polymerization, A. baumannii (5 
log10 CFU/ml) was suspended in SWF with or without the MIC of PDAs to each well in 
duplicates. The plates were incubated for 48 h, and the polymerized collagen was subsequently 
dissolved using collagenase solution (500 μl/ml in PBS), followed by incubation for 60 min at 
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37oC. A. baumannii counts were determined using serial dilution and plating on TSA. The 
experiment was repeated three times. 
2.7. Confocal microscopy 
          The three-dimensional structure of A. baumannii biofilm treated with or without TC or EG 
was visualized in situconfocal laser scanning microscopy using a Leica true confocal scanner 
SP2 microscope with a water immersion lens (Loehfelm et al., 2008). A. baumannii exposed to 
the MIC of TC or EG in TSB was allowed to form biofilms on a Lab-Tech eight-chamber no.1 
borosilicate glass coverslip system (Lab-tek, Nalge Nunc International, Rochester, NY, USA) by 
incubating it at 37oC for 48 h, followed by gently washing with PBS three times. The live and 
dead bacteria in the biofilm were imaged after staining with 2.5 M Syto9 (Molecular Probes, 
Eugene, Oregon, USA) and 5 M propidium iodide (Molecular Probes) for 5 min prior to 
imaging on a Nikon AIR laser scanning confocal. Syto9 is a live cell permanent DNA stain, 
while propidium iodide is a nucleic acid stain that can only enter dead or dying cells. Syto 
staining was imaged with 488 nm excitation and a 525/50 emission filter, whereas propidium 
iodide staining was imaged with 560 nm excitation and a 600/50 emission filter. For each 
treatment, four randomly selected fields were analyzed. Optical sections of approximately 0.2 
μm in height were collected starting from the bottom and moving upward through the entire 
biofilm. 
2.8.Effect of TC and EG on biofilm genes in A. baumannii 
2.8.1. RNA extraction and cDNA synthesis 
To study the effect of TC and EGon genes critical for biofilm formation in A. baumannii, 
bacterial cultures (Navel-17, OIFC-109) were grown separately in TSB with or without the SIC 
of TC or EG at 37oC to mid-log phase. Control without any PDA was also included. After 
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incubation, the cultures were subjected to centrifugation (12000 x g, 15 min, 4oC), and the 
resultant pellet was added with 0.5 ml of RNAase free, sterile water and 1 ml of RNA protect 
reagent (Qiagen, Valencia, CA, USA). The total RNA from each sample was extracted using the 
RNeasy mini kit (Qiagen), and the manufacturer’s instructions were followed in estimating the 
total RNAusing Nanodrop (ThermoFisher Scientific, Waltham, MA, USA). Super-script II 
reverse transcriptase kit (Invitrogen, Carlsbad, CA, USA) was used for cDNA synthesis, and the 
resultant cDNA was used as the template for RT-qPCR. The amplified product was detected 
using SYBR Green reagents. 
2.8.2. Real-Time Quantitative PCR (RT-qPCR) 
The biofilm genes of A. baumannii analysed for the gene expression study included csuE, 
that codes for putative tip adhesin critical forinitiation of biofilm formation (Gaddy and Actis, 
2009); bfmS, a component of the regulatory system that controls csuE (Liou et al., 2014); and 
ompA, a critical gene for attachment to eukaryotic cells for biofilm formation (Liou et al., 2014). 
Previously published primers were used for csuE and bfmS, while the primer pair for ompA was 
designed using Basic Logic Alignment Search Tool (BLAST) (Table 1). The custom synthesized 
primers were obtained from Integrated DNA Technologies (Foster City, CA, USA). RT-qPCR 
was performed with StepOnePlusTM Real Time PCR system (Applied Biosystems, Foster city, 
CA, USA) using the SYBR green assay (Applied Biosystems) under custom thermal cycling 
conditions with the normalized RNA as the template (Bookout and Mangelsdorf, 2003). 
Duplicate samples were analyzed and standardized against 16S rRNA gene expression. The 
relative changes in mRNA expression levels were determined using comparative threshold cycle 
(CT) method (2-CT) between the control and the treatments. 
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2.9. Statistical analysis  
A completely randomized design was used for the study. All the experiments had 
duplicate samples and were repeated three times. The data for each treatment and control were 
pooled and analyzed using the PROC GENMOD procedure of Statistical Analysis Software 
(SAS ver. 9.4; Institute, Inc., Cary, NC, USA). A Pvalue of < 0.05 was considered to be 
statistically significant. 
3. RESULTS AND DISCUSSION 
          Skin is the largest organ in the human body and constitutes an integral part of the innate 
immune system; it is the first line of defense against any infection by preventing microbial 
adhesion and invasion (Nizet et al., 2001; Schroder and Harder, 2006). Skin is colonized with 
microbial populations consisting of resident flora and transient microflora (Price, 1938; 
Mackowiak, 1982). However, when a disruption occurs to the anatomical structure of the skin, 
an onset of infection can happen, if the homeostatic physiological conditions are not rapidly 
restored (Boateng and Catanzano, 2015). While studying the distribution of Acinetobacter 
species on human skin, Seifert et al. (1997) reported that Acinetobacter spp. colonized in 75% of 
patients, with the colonization rates increasing with the length of stay in hospitals. A. baumannii 
is considered as one of the most significant bacteria causing persistent wound infections, 
especially in burn patients (Uygur et al., 2009) and combat-related injuries (Johnson et al., 2007; 
Scott et al., 2007). Previous studies have reported the formation of biofilms by A. baumannii on 
human skin surfaces (Guerrero et al., 2010; deBreij et al., 2012). Besides its multi-drug 
resistance, difficulties in treating A. baumannii wound infections areattributed to its ability to 
form biofilms, which resist the action of host immune defenses as well as antimicrobial 
interventions, thereby delaying the healing process (Dallo and Weitao, 2010). Bacterial biofilms 
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are also important in chronic wound infections (Martin et al., 2010);60% of the chronic wounds 
testedin hospitals containbiofilms (James et al., 2008). Although it is not clearly recognized how 
the wound-associated microflora affect healing (Percival et al., 2012), pathogens are known to 
produce extracellular adherence proteins which can inhibit action of leucocytes besidesexerting 
anti-angiogenic and anti-inflammatory effects (Athanaspoulos et al., 2006). Therefore, in this 
study, we investigated efficacy of TC and EG in reducing A. baumannii colonization of human 
keratinocytes as well as inhibiting its biofilm in an in vitro wound model (Werthen et al., 2010). 
The SIC of TC and EG against A. baumannii were found to be 1.1 mM (0.015 %) and 1.8 
mM (0.03 %), respectively, while the MICs of TC and EG were 4.0 mM (0.05% TC and 0.065 % 
EG (data not shown). The efficacy the MIC of TC and EG in reducing adhesion to and invasion 
of keratinocytes HEK001 by three clinical strains of A. baumannii is presented in Fig 1-3. The 
results revealed that both TC and EG were effective in reducing A. baumannii adhesion to and 
invasion of HEK001 cells compared to the controls (P < 0.05). The MIC of TC reduced A. 
baumannii adhesion and invasion of keratinocytes by ~1.8 to 2 log CFU/ml, while EG reduced 
adhesion and invasion of cells by ~2 log and ~2.5-3 log10 CFU/ml, respectively compared to 
controls (P < 0.05). No significant difference was observed between TC and EG in reducing A. 
baumannii adhesion to HEK001 cells, however, EG was found to be more effective than TC in 
reducing invasion in A. baumannii Naval-17 (P < 0.05). Ethanol, which was used as a diluent for 
TC and EG, did not exert any significant effect on the adhesion-invasion properties of A. 
baumannii compared to control (P > 0.05). 
          The effect of PDAs on A. baumannii biofilm formation in the in vitro wound model is 
presented in Fig. 4-6. The MIC of both TC and EG significantly reduced biofilm-associated A. 
baumannii counts after 24 and 48 h of incubation at 37OC compared to control (P < 0.05). After 
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24 h of incubation, the MIC of TC and EG resulted in ~1.510 log and ~2 log10 CFU/ml reduction 
in A. baumannii counts respectively, compared to control (P < 0.05). However, after 48 h of 
incubation, TC and EG decreased A. baumannii counts by ~ 3-3.5 log10 CFU/ml and ~ 4 log 
10CFU/ml, respectively compared to control (P < 0.05). In addition, EG was generally found to 
be more effective than TC in inhibiting biofilm, particularly in A. baumannii Naval-17 (P < 
0.05).  
The effect of TC and EG on A. baumannii biofilm structure, as revealed by confocal laser 
scan microscopy, is depicted in Fig 7. In A. baumannii not exposed to TC/EG (control), a thick 
uniform layer of biofilm embedded with live cells (stained green by SYTO Green dye) was 
observed (Fig 7A), while A. baumannii treated with the MIC of TC and EG revealed breaks in 
the biofilm with the presence of dead cells (stained by red propidium iodide dye) (Fig 7 B-C). In 
addition, the thickness of the biofilms in the treatments (<10 m) was lesser than in controls (> 
20 m).  
The effect of PDAs on the expression of critical biofilm genes in A. baumannii is 
depicted in Fig. 8-10. It was observed that in A. baumannii Naval -17 when compared to the 
control, TC significantly down-regulated the expression the expression of bfms, csuE and ompA 
by ~2.5, ~1.5 and ~2.5 folds, respectively (P < 0.05). Similarly, EG was found to decrease the 
expression of bfms, csuE and ompA by ~ 3.5, 6 and 4 folds, respectively (Fig 8). In A. baumannii 
OIFC 109, TC down-regulated the expression of bfmS and csuE by ~2.7 and ~16 fold, 
respectively (P < 0.05), while EG decreased the expression of bfmS, csuE and ompA by ~25, ~11 
and ~23 folds, respectively (P <0.05) (Fig 9). These results support the findings from the in vitro 
wound biofilm assay as well as the confocal microscopy result. 
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The efficacy of antibiotics for treating A. baumannii wound infections is limited owing to 
its multi-drug resistance (Karageorgopoulos and Falagas, 2008; Giamarellou et al., 2008). 
Although studies have shown the efficacy of chlorhexidine as an antiseptic for skin disinfection 
of A. baumannii (Evans et al., 2010; de-Breij et al., 2012), it has been implicated to exert toxicity 
to fibroblasts and prevent wound healing (Lucarotti et al., 1990; Hidalgo and Dominquez, 2001). 
In addition, A. baumannii resistant to 1% chlorhexidine has been isolated from surfaces of soap 
dispensers (Brooks et al., 2002). The results from this study indicated that TC and EG were 
effective for reducing A. baumannii colonization of skin cells, and inhibiting bacterial biofilm 
formation in a collagen matrix. Therefore, TC and EG represent potential antimicrobial agents 
for treating A. baumannii wound infections, where they could be used as ingredients in 
antimicrobial ointments and creams. However, follow up studies on their safety and efficacy in 
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 Table 1. List of primers used for RT-PCR for targeting biofilm genes in A. baumannii 
 
Gene Sequence (5’3’) Function 
 











 csuEb(F) TACTGGTTTGGCCTATCC 
Putative tip 













control (R) TA CTTGTTACGACTTCACCCCA 
 
























Fig 1. Effect of Trans-cinnamaldehyde (TC) and Eugenol (EG) on A. baumannii Naval-17 
adhesion to and invasion of HEK001 keratinocytes. A. baumannii either alone or with 
TC/EG/ethanol (diluent) was added to HEK001 monolayer. The adhered or invaded bacterial 
counts were determined by broth dilution. 





















Fig 2. Effect of Trans-cinnamaldehyde (TC) and Eugenol (EG) on A. baumannii OIFC 109 
adhesion to and invasion of HEK001 keratinocytes. 
A. baumannii either alone or with TC/EG/ethanol(diluent) was added to HEK001 monolayer. 
The adhered or invaded bacterial counts were determined by broth dilution. 






























































Fig 3. Effect of Trans-cinnamaldehyde (TC) and Eugenol (EG) on A. baumannii WC-487 
adhesion to and invasion of HEK001 keratinocytes 
A. baumannii either alone or with TC/EG/ethanol(diluent) was added to HEK001 monolayer. 
The adhered or invaded bacterial counts were determined by broth dilution. 































































Fig 4. Effect of Trans-cinnamaldehyde (TC) and Eugenol (EG) on A. baumannii Naval -17 
biofilm in an in vitro wound model. A. baumannii exposed to MICs of TC/EG were allowed to 
form a biofilm on a collagen matrix at 37OC. Bacterial counts were enumerated after 24 and 48 h 























































Fig 5. Effect of TC and EG on A. baumannii OIFC 109 biofilm in an in vitro wound model. A. 
baumannii exposed to MICs of TC/EG were allowed to form a biofilm on a collagen matrix at 
37OC. Bacterial counts were enumerated after 24 and 48 h of incubation.Bars with different 

























































Fig 6. Effect of TC and EG on A. baumannii WC-487 biofilm in an in vitro wound model. A. 
baumannii exposed to MICs of TC/EG were allowed to form a biofilm on a collagen matrix at 
37OC. Bacterial counts were enumerated after 24 and 48 h of incubation.Bars with different 


























































Fig 7. Scanning confocal micrographs of Acinetobacter baumannii Naval-17 biofilm  
(A) without TC/EG treatment,  (B) after treatment with the MIC of trans-cinnamaldehyde (TC; 
4.0 mM), (C) after treatment with the MIC of eugenol (EG; 4.0 mM). The bacteria were first 
treated with TC and EG and allowed to form a biofilm at 37OC for 48 h on borosilicate glass 
coverslip. Live/Dead staining of the biofilm was done with 2.5 M Syto9 and 5 M propidium 
iodide. 




Fig 8. Effect of TC and EG on biofilm genes in A. baumannii Naval-17 *(P<0.05) 
A. baumannii Naval-17 was exposed to SICs of TC or EG and RT-qPCR was done to test the 
effect of PDAs on critical biofilm genes in A. baumannii. Bacteria not exposed to TC/EG served 















































Fig 9. Effect of TC and EG on biofilm genes in A. baumannii OIFC 109  
A.baumannii OIFC 109 was exposed to SICs of TC or EG and RT-qPCR was done to test the 
effect of PDAs on critical biofilm genes in A. baumannii. Bacteria not exposed to TC/EG served 



























































































          Acinetobacter baumannii has emerged as a significant, multi-drug resistant (MDR), 
nosocomial pathogen causing meningitis, bacteremia, urinary tract infections and wound 
infections in humans. The widespread presence of this pathogen in the environment, including 
soil and water, potentially leads to the contamination of foods, especially fresh produce In 
addition, A. baumannii is resistant to almost all currently used antibiotics, making the treatment 
of infections difficult. This underscores the need for alternative strategies for controlling the 
pathogen. 
          This study investigated the prevalence of MDR A. baumannii on fresh vegetables, and the 
efficacy of chlorine as a water disinfectant in killing the bacterium. In addition, the study also 
investigated the potential of two plant-derived antimicrobials (PDAs), trans-cinnamaldehyde 
(TC) and eugenol (EG), for controlling antibiotic resistance and virulence in A. baumannii. The 
first objective of the study investigated the prevalence of MDR A. baumannii on vegetables such 
as carrots, lettuce and potatoes collected from farmers’ markets in Connecticut. The results 
revealed that out of 100 samples of each vegetable tested, A. baumannii was recovered from only 
two samples of potato and one sample of lettuce. Further, no carrot sample was positive for the 
bacterium. However, besides A. baumannii, several other MDR, opportunistic human pathogens 
such as Burkholderia cepacia, Stenotrophomonas maltophilia and Pseudomonas luteolawere 
recovered from the vegetables. Burkholderia cepacia isolates showed a high resistance to 
ceftriaxone (91%), colistin-sulphate (83%), erythromycin (79%) and streptomycin (70%); 
Pseudomonas luteola to colistin-sulphate (91%) and imipenem (83%); S. maltophilia to colistin-
sulphate (100%), ceftriaxone (88%), cefepime (66%), erythromycin (66%) and imipenem (55%); 
and all isolates of A. baumannii were resistant to imipenem, ceftriaxone, erythromycin and 
streptomycin. The results indicated the presence of MDR bacteria, including A. baumannii on 
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fresh produce, thereby highlighting the potential health risk to consumers, especially those who 
are immune-compromised.  
          The second objective of this study was to test the efficacy of chlorine as a water 
disinfectant in killing A. baumannii. In addition, RT-qPCR was used to determine the effect of 
chlorine on the antibiotic resistance genes in A. baumannii. Results revealed that all the tested A. 
baumannii strains survived a chlorine concentration up to 4 pm, which typically used for water 
disinfection. Further, RT-qPCR analysis revealed an up-regulation of all or some of the antibiotic 
resistance genes in the tested A. baumannii isolates, indicating an induction of antibiotic 
resistance in the presence of chlorine. This is significant as chlorine is widely used as a sanitizer 
for water and fresh produce. 
          As routine cultural methods of screening A. baumannii from biological materials are 
cumbersome, the development of a real-time PCR (RT-qPCR) for rapid and specific detection of 
A. baumannii in water and blood was the third objective in the study. The RT-qPCR used a 
TaqMan primer-probe set targeting a highly conserved 102-bp DNA sequence of an efflux pump 
gene, adeT found in A. baumannii. All tested A. baumannii isolates yielded a 107-bp PCR 
product, while none of the negative isolates, including other closely related Acinetobacter 
species produced any amplification. The sensitivity of PCR was 3 log10 CFU/ml A. baumannii or 
0.1 ng/mL of A. baumannii DNA. However, upon enrichment, the PCR detected 2 log and 1 log 
CFU/ml of A. baumannii in water after 6 h and 14 h of incubation at 37oC, respectively.  
          Beta-lactam antibiotics are the most commonly used antibiotics used in the treatment of 
human infections. Since A. baumannii is resistant to most currently known antibiotics, the fourth 
objective of the study investigated the efficacy of TC and EG in decreasing A. baumannii’s 
resistance to seven -lactam antibiotics. The results from broth dilution assay revealed that both 
 179 
TC and EG increased the sensitivity of A. baumannii to all antibiotics tested (P<0.05). In 
addition, RT-qPCR data revealed that TC and EG down-regulated the expression of majority of 
the genes conferring resistance to beta-lactam antibiotics, especially blaP and adeABC. The 
results suggest that TC and EG could potentially be used along with β-lactam antibiotics for 
controlling MDR A. baumannii infections; however, their clinical significance needs to be 
determined using in vivo studies. 
          The fifth objective of the study was to investigate the efficacy of TC and EG in decreasing 
A. baumannii adhesion to and invasion of normal human keratinocytes, and inhibiting A. 
baumannii biofilm formation in an in vitro wound model. Both TC and EG significantly reduced 
A. baumannii adhesion to the skin cells by ~2-2.5 log10 CFU/ml and invasion of the cells by ~2-3 
log CFU/m compared to controls (P<0.05). Further, both PDAs inhibited biofilm formation by A. 
baumannii in the wound model. These results suggest the potential use of TC and EG for treating 
A. baumannii wound infections. 
 
 
 
